##### Table of Contents





UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549





FORM 10-Q





(Mark One)

|x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------------

For the quarterly period ended June 30, 2010

OR



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------

For the transition period from              to
            .

Commission File Number 333-129951





INNOPHOS, INC.

(Exact Name of Registrant as Specified in its Charter)







|                                                               |  |                                     
|-------------------------------------------------------------- |  | ------------------------------------
|Delaware                                                       |  | 20-1380712                          
|(State or Other Jurisdiction of
Incorporation or Organization) |  | (I.R.S. Employer
Identification No.)
|                                                               | 
|259 Prospect Plains Road
Cranbury, New Jersey                  |  | 08512                               
|(Address of Principal Executive Offices)                       |  | (Zip Code)                          

Registrants Telephone Number, Including Area Code: (609) 495-2495





Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90
days.    Yes  x    No   ̈

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such
files).    Yes   ̈    No   ̈

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller
reporting company. See definition of accelerated filer, large accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer   ̈    Accelerated
Filer   ̈    Non-accelerated
filer  x    Smaller reporting company   ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).    Yes   ̈    No  x

As of June 30, 2010, the registrant had 1,000 shares of common stock outstanding









---

##### Table of Contents

TABLE OF CONTENTS



|           |  |                                                                                       |  |     
|---------- |  | ------------------------------------------------------------------------------------- |  | ----
|           |  |                                                                                       |  | Page
|PART I     |  |                                                                                      
|Item 1.    |  | Financial Statements                                                                  |  | 3   
|Item 2.    |  | Managements Discussion and Analysis of Financial Condition and Results of Operations |  | 24  
|Item 3.    |  | Quantitative and Qualitative Disclosures About Market Risk                            |  | 32  
|Item 4T.   |  | Controls and Procedures                                                               |  | 33  
|           | 
|PART II    |  |                                                                                      
|Item 1.    |  | Legal Proceedings                                                                     |  | 34  
|Item 1A.   |  | Risk Factors                                                                          |  | 34  
|Item 2.    |  | Unregistered Sales of Equity Securities and Use of Proceeds                           |  | 34  
|Item 3.    |  | Defaults Upon Senior Securities                                                       |  | 34  
|Item 4.    |  | (Removed and Reserved)                                                                |  | 34  
|Item 5.    |  | Other Information                                                                     |  | 34  
|Item 6.    |  | Exhibits                                                                              |  | 34  
|           | 
|Signatures |  | 35                                                                                   



2



---

##### Table of Contents

PART I



|ITEM 1. | FINANCIAL STATEMENTS
|------- | --------------------

INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(Dollars in thousands)



|                                            |  |              |         |                  |   |        
|------------------------------------------- |  | ------------ | ------- | ---------------- | - | -------
|                                            |  | June 30,2010 |         | December 31,2009
|ASSETS                                      |  |              |         |                  |   |        
|Current assets:                             |  |              |         |                  |   |        
|Cash and cash equivalents                   |  | $            | 66,667  |                  | $ | 132,222
|Restricted cash                             |  |              |        |                  |   | 1,749  
|Accounts receivable, net                    |  |              | 78,807  |                  |   | 56,345 
|Inventories                                 |  |              | 115,194 |                  |   | 113,636
|Other current assets                        |  |              | 49,504  |                  |   | 45,638 
|                                            |  |              |         |                  |   |        
|Total current assets                        |  |              | 310,172 |                  |   | 349,590
|Property, plant and equipment, net          |  |              | 196,642 |                  |   | 204,527
|Goodwill                                    |  |              | 51,706  |                  |   | 51,706 
|Intangibles and other assets, net           |  |              | 49,353  |                  |   | 51,483 
|                                            |  |              |         |                  |   |        
|Total assets                                |  | $            | 607,873 |                  | $ | 657,306
|                                            |  |              |         |                  |   |        
|LIABILITIES AND STOCKHOLDERS EQUITY        |  |              |         |                  |   |        
|Current liabilities:                        |  |              |         |                  |   |        
|Current portion of long-term debt           |  | $            |        |                  | $ |       
|Accounts payable, trade and other           |  |              | 33,091  |                  |   | 32,580 
|Other current liabilities                   |  |              | 37,991  |                  |   | 54,603 
|                                            |  |              |         |                  |   |        
|Total current liabilities                   |  |              | 71,082  |                  |   | 87,183 
|Long-term debt                              |  |              | 190,000 |                  |   | 190,000
|Other long-term liabilities                 |  |              | 34,771  |                  |   | 37,920 
|                                            |  |              |         |                  |   |        
|Total liabilities                           |  |              | 295,853 |                  |   | 315,103
|                                            |  |              |         |                  |   |        
|Commitments and contingencies (see note 11) |  |              |         |                  |   |        
|Stockholders equity                        |  |              | 312,020 |                  |   | 342,203
|                                            |  |              |         |                  |   |        
|Total stockholders equity                  |  |              | 312,020 |                  |   | 342,203
|                                            |  |              |         |                  |   |        
|Total liabilities and stockholders equity  |  | $            | 607,873 |                  | $ | 657,306
|                                            |  |              |         |                  |   |        

See notes to condensed consolidated financial
statements



3



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Operations (Unaudited)

(Dollars in thousands)



|                                    |  |                                 |         |                                 |   |         |  
|----------------------------------- |  | ------------------------------- | ------- | ------------------------------- | - | ------- | -
|                                    |  | Three months endedJune 
30,2010 |         | Three months endedJune 
30,2009 |  
|Net sales                           |  | $                               | 184,032 |                                 | $ | 166,766 |  
|Cost of goods sold                  |  |                                 | 136,971 |                                 |   | 117,371 |  
|                                    |  |                                 |         |                                 |   |         |  
|Gross profit                        |  |                                 | 47,061  |                                 |   | 49,395  |  
|                                    |  |                                 |         |                                 |   |         |  
|Operating expenses:                 |  |                                 |         |                                 |   |         |  
|Selling, general and administrative |  |                                 | 13,770  |                                 |   | 17,424  |  
|Research & development expenses     |  |                                 | 614     |                                 |   | 533     |  
|                                    |  |                                 |         |                                 |   |         |  
|Total operating expenses            |  |                                 | 14,384  |                                 |   | 17,957  |  
|                                    |  |                                 |         |                                 |   |         |  
|Operating income                    |  |                                 | 32,677  |                                 |   | 31,438  |  
|Interest expense, net               |  |                                 | 4,428   |                                 |   | 5,476   |  
|Foreign exchange loss (gain)        |  |                                 | 711     |                                 |   | (690    | )
|Other income, net                   |  |                                 |        |                                 |   | 208     |  
|                                    |  |                                 |         |                                 |   |         |  
|Income before income taxes          |  |                                 | 27,538  |                                 |   | 26,444  |  
|Provision for income taxes          |  |                                 | 9,216   |                                 |   | 9,946   |  
|                                    |  |                                 |         |                                 |   |         |  
|Net income                          |  | $                               | 18,322  |                                 | $ | 16,498  |  
|                                    |  |                                 |         |                                 |   |         |  

See notes to condensed consolidated financial statements

INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Operations (Unaudited)

(Dollars in thousands)



|                                    |  |                               |         |                               |   |         |  
|----------------------------------- |  | ----------------------------- | ------- | ----------------------------- | - | ------- | -
|                                    |  | Six months endedJune 
30,2010 |         | Six months endedJune 
30,2009 |  
|Net sales                           |  | $                             | 353,039 |                               | $ | 357,583 |  
|Cost of goods sold                  |  |                               | 269,272 |                               |   | 238,395 |  
|                                    |  |                               |         |                               |   |         |  
|Gross profit                        |  |                               | 83,767  |                               |   | 119,188 |  
|                                    |  |                               |         |                               |   |         |  
|Operating expenses:                 |  |                               |         |                               |   |         |  
|Selling, general and administrative |  |                               | 28,288  |                               |   | 31,400  |  
|Research & development expenses     |  |                               | 1,177   |                               |   | 1,062   |  
|                                    |  |                               |         |                               |   |         |  
|Total operating expenses            |  |                               | 29,465  |                               |   | 32,462  |  
|                                    |  |                               |         |                               |   |         |  
|Operating income                    |  |                               | 54,302  |                               |   | 86,726  |  
|Interest expense, net               |  |                               | 8,848   |                               |   | 11,541  |  
|Foreign exchange loss (gain)        |  |                               | 481     |                               |   | (275    | )
|Other income, net                   |  |                               |        |                               |   |        |  
|                                    |  |                               |         |                               |   |         |  
|Income before income taxes          |  |                               | 44,973  |                               |   | 75,460  |  
|Provision for income taxes          |  |                               | 15,307  |                               |   | 27,602  |  
|                                    |  |                               |         |                               |   |         |  
|Net income                          |  | $                             | 29,666  |                               | $ | 47,858  |  
|                                    |  |                               |         |                               |   |         |  

See notes to condensed consolidated financial statements



4



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Dollars in thousands)



|                                                                                  |  |                               |         |   |                               |   |          |  
|--------------------------------------------------------------------------------- |  | ----------------------------- | ------- | - | ----------------------------- | - | -------- | -
|                                                                                  |  | Six months endedJune 
30,2010 |         |   | Six months endedJune 
30,2009 |  
|Cash flows from operating activities                                              |  |                               |         |   |                               |   |          |  
|Net income                                                                        |  | $                             | 29,666  |   |                               | $ | 47,858   |  
|Adjustments to reconcile net income to net cash provided by operating activities: |  |                               |         |   |                               |   |          |  
|Depreciation and amortization                                                     |  |                               | 24,914  |   |                               |   | 23,849   |  
|Amortization of deferred financing charges                                        |  |                               | 708     |   |                               |   | 1,934    |  
|Deferred income tax benefit                                                       |  |                               | (1,161  | ) |                               |   | (1,764   | )
|Deferred profit sharing                                                           |  |                               | (414    | ) |                               |   | (230     | )
|Share-based compensation                                                          |  |                               | 1,916   |   |                               |   | 1,219    |  
|Changes in assets and liabilities:                                                |  |                               |         |   |                               |   |          |  
|Decrease (increase) in restricted cash                                            |  |                               | 1,749   |   |                               |   | (1,748   | )
|(Increase) decrease in accounts receivable                                        |  |                               | (22,462 | ) |                               |   | 12,558   |  
|(Increase) decrease in inventories                                                |  |                               | (1,558  | ) |                               |   | 31,243   |  
|(Increase) (decrease) in other current assets                                     |  |                               | (6,008  | ) |                               |   | 1,187    |  
|Increase (decrease) in accounts payable                                           |  |                               | 511     |   |                               |   | (1,731   | )
|(Decrease) increase in other current liabilities                                  |  |                               | (16,612 | ) |                               |   | 4,784    |  
|Changes in other long-term assets and liabilities                                 |  |                               | 383     |   |                               |   | 638      |  
|                                                                                  |  |                               |         |   |                               |   |          |  
|Net cash provided from operating activities                                       |  |                               | 11,632  |   |                               |   | 119,797  |  
|                                                                                  |  |                               |         |   |                               |   |          |  
|Cash flows from investing activities:                                             |  |                               |         |   |                               |   |          |  
|Capital expenditures                                                              |  |                               | (15,308 | ) |                               |   | (7,640   | )
|                                                                                  |  |                               |         |   |                               |   |          |  
|Net cash used for investing activities                                            |  |                               | (15,308 | ) |                               |   | (7,640   | )
|                                                                                  |  |                               |         |   |                               |   |          |  
|Cash flows from financing activities:                                             |  |                               |         |   |                               |   |          |  
|Return of capital to parent                                                       |  |                               | (62,054 | ) |                               |   | (26,161  | )
|Excess tax benefits from exercise of stock options                                |  |                               | 175     |   |                               |   | 2        |  
|Deferred financing costs                                                          |  |                               |        |   |                               |   | (1,050   | )
|Principal payments of term-loan                                                   |  |                               |        |   |                               |   | (126,500 | )
|                                                                                  |  |                               |         |   |                               |   |          |  
|Net cash used for financing activities                                            |  |                               | (61,879 | ) |                               |   | (153,709 | )
|                                                                                  |  |                               |         |   |                               |   |          |  
|Net change in cash                                                                |  |                               | (65,555 | ) |                               |   | (41,552  | )
|Cash and cash equivalents at beginning of period                                  |  |                               | 132,222 |   |                               |   | 124,623  |  
|                                                                                  |  |                               |         |   |                               |   |          |  
|Cash and cash equivalents at end of period                                        |  | $                             | 66,667  |   |                               | $ | 83,071   |  
|                                                                                  |  |                               |         |   |                               |   |          |  

See notes to condensed consolidated financial statements



5



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Statements of Stockholders Equity and Other Comprehensive Income (Loss) (Unaudited)

(Dollars in thousands)



|                                                        |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   |         |  
|------------------------------------------------------- |  | ---------------- | ------- | -------------- | - | ------- | ------------------------------------------ |  | - | ------------------------ | - |  | - | ------- | -
|                                                        |  | RetainedEarnings |         | Paid-inCapital |   |         | AccumulatedOtherComprehensiveIncome/(Loss) |  |   | TotalShareholdersEquity |  
|Balance, January 1, 2009                                |  | $                | 194,197 |                | $ | 99,658  |                                            |  | $ | (2,024                   | ) |  | $ | 291,831 |  
|Net income                                              |  |                  | 65,427  |                |   |         |                                            |  |   |                          |   |  |   | 65,427  |  
|Change in pension and post-retirement plans, net of tax |  |                  |         |                |   |         |                                            |  |   | (226                     | ) |  |   | (226    | )
|                                                        |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   |         |  
|Net income and other comprehensive income, net of tax   |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   | 65,201  |  
|Stock-based compensation                                |  |                  |         |                |   | 3,367   |                                            |  |   |                          |   |  |   | 3,367   |  
|Return of capital                                       |  |                  |         |                |   | (18,196 | )                                          |  |   |                          |   |  |   | (18,196 | )
|                                                        |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   |         |  
|Balance, December 31, 2009                              |  | $                | 259,624 |                | $ | 84,829  |                                            |  | $ | (2,250                   | ) |  | $ | 342,203 |  
|                                                        |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   |         |  
|Net income                                              |  |                  | 29,666  |                |   |         |                                            |  |   |                          |   |  |   | 29,666  |  
|Change in pension and post-retirement plans, net of tax |  |                  |         |                |   |         |                                            |  |   | 210                      |   |  |   | 210     |  
|                                                        |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   |         |  
|Net income and other comprehensive income, net of tax   |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   | 29,876  |  
|Stock-based compensation                                |  |                  |         |                |   | 1,916   |                                            |  |   |                          |   |  |   | 1,916   |  
|Return of capital                                       |  |                  |         |                |   | (61,975 | )                                          |  |   |                          |   |  |   | (61,975 | )
|                                                        |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   |         |  
|Balance, June 30, 2010                                  |  | $                | 289,290 |                | $ | 24,770  |                                            |  | $ | (2,040                   | ) |  | $ | 312,020 |  
|                                                        |  |                  |         |                |   |         |                                            |  |   |                          |   |  |   |         |  

See notes to condensed consolidated financial statements



6



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)

1. Basis of Statement Presentation:

Summary of Significant Accounting Policies

Innophos, Inc. is a wholly-owned subsidiary of Innophos Investments Holdings, Inc. (Investments Holdings), incorporated under
the laws of the State of Delaware. Innophos Investments Holdings, Inc. is a wholly-owned subsidiary of Innophos Holdings, Inc. (Holdings).

Interim Financial Statements

The accompanying unaudited condensed consolidated financial statements of Innophos Holdings, Inc. and Subsidiaries, or Company, have been
prepared in accordance with generally accepted accounting principles for interim financial reporting and do not include all disclosures required by generally accepted accounting principles for annual financial reporting, and should be read in
conjunction with the audited consolidated and combined financial statements of the Company at December 31, 2009 and for the three years then ended.

The accompanying unaudited condensed consolidated financial statements of the Company reflect all adjustments, consisting only of normal
recurring accruals, which management considers necessary for a fair statement of the results of operations for the interim periods and is subject to year end adjustments. The results of operations for the interim periods are not necessarily
indicative of the results for the full year. The December 31, 2009 condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the
United States of America.

Recently Issued Accounting Standards

In June 2009, the FASB issued an amendment to ASC topic 860 Transfers and Servicing. Among other items the provision removes the concept
of a qualifying special-purpose entity and clarifies that the objective of paragraph ASC 860-10-40-4 is to determine whether a transferor and all of the entities included in the transferors financial statements being presented have surrendered
control over transferred financial assets. This pronouncement is effective January 1, 2010. The implementation of this standard did not have a material impact on the Companys consolidated financial position and results of operations.

In June 2009, the FASB issued an amendment to ASC topic 810 Consolidation. The provisions of ASC 810 provide guidance in
determining whether an enterprise has a controlling financial interest in a variable interest entity. This determination identifies the primary beneficiary of a variable interest entity as the enterprise that has both the power to direct the
activities of a variable interest entity that most significantly impacts the entitys economic performance, and the obligation to absorb losses or the right to receive benefits of the entity that could potentially be significant to the variable
interest entity. This pronouncement also requires ongoing reassessments of whether an enterprise is the primary beneficiary and eliminates the quantitative approach previously required for determining the primary beneficiary. New provisions of this
pronouncement are effective January 1, 2010. The implementation of this standard did not have a material impact on the Companys consolidated financial position and results of operations.

In October 2009, the FASB issued Accounting Standards Update (ASU) No. 2009-13, Multiple-Deliverable Revenue Arrangements  a
consensus of the FASB Emerging Issues Task Force (EITF), which provides principles for allocation of consideration among its multiple-elements, allowing more flexibility in identifying and accounting for separate deliverables under an arrangement.
The EITF introduces an estimated selling price method for valuing the elements of a bundled arrangement if vendor-specific objective evidence or third-party evidence of selling price is not available, and significantly expands related disclosure
requirements. This standard is effective on a prospective basis for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Alternatively, adoption may be on a retrospective basis, and early
application is permitted. The implementation of this standard will not have a material impact on the Companys consolidated financial position and results of operations.



7



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



2. Dividends:

The following is the dividend activity for the three and six months ended June 30, 2010 and June 30, 2009:



|                               |  |                           |       |                         |   |       |  |      |       |  |   |      
|------------------------------ |  | ------------------------- | ----- | ----------------------- | - | ----- |  | ---- | ----- |  | - | -----
|                               |  | Three Months EndedJune 30 |       | Six Months EndedJune 30
|                               |  | 2010                      |       | 2009                    |   | 2010  |  | 2009
|Dividends declared - per share |  | $                         | 0.17  |                         | $ | 0.17  |  | $    | 0.34  |  | $ | 0.34 
|Dividends declared - aggregate |  |                           | 3,641 |                         |   | 3,619 |  |      | 7,281 |  |   | 7,230
|                               |  |                           |       |                        
|Dividends paid - per share     |  |                           | 0.17  |                         |   | 0.17  |  |      | 0.34  |  |   | 0.34 
|Dividends paid - aggregate     |  |                           | 3,640 |                         |   | 3,611 |  |      | 7,273 |  |   | 7,201

As all of the
business for Holdings and Innophos Investments Holdings, Inc. are transacted through Innophos, Inc. and Subsidiaries, Holdings and Innophos Investments Holdings, Inc. are dependent on earnings and distribution of funds from Innophos, Inc. and
Subsidiaries.

3. Share-Based Compensation:

Holdings compensation programs include share-based payments. The primary share-based awards and their general terms and conditions
currently in effect are as follows:



| |  |  | Restricted stock grants, which entitle the holder to receive, at the end of each vesting term, a specified number of shares of Holdings common stock,
and which also entitle the holder to receive dividends paid on such grants throughout the vesting period.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Stock options, which entitle the holder to purchase, after the end of a vesting term, a specified number of shares of Holdings common stock at an
exercise price per share set equal to the market price of the Companys common stock on the date of grant.
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Performance share awards which entitle the holder to receive, at the end of a vesting term, a number of shares of Holdings common stock, within a range
of shares from zero to a specified maximum (generally 200%), calculated using a three year future average return on invested capital (i.e. the three year period 2010-2012 for a 2010 award) as defined solely by reference to Holdings own activities.
Dividends will accrue over the vesting period and are paid on performance share awards when fully vested.
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Annual stock retainer grants, which entitle independent members of the Board of Directors to receive a number of shares of Holdings common stock equal
to a fixed retainer value.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Since these programs benefit the employees of Innophos, Inc. all amounts have
been recorded in our consolidated results.



8



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



The following table summarizes the components of share-based compensation expense, all
of which has been classified as selling, general and administrative expense:



|                                       |  |                    |       |                  |   |              |  |              |       |  |   |      
|-------------------------------------- |  | ------------------ | ----- | ---------------- | - | ------------ |  | ------------ | ----- |  | - | -----
|                                       |  | Three Months Ended |       | Six Months Ended
|                                       |  | June 30,2010       |       | June 30,2009     |   | June 30,2010 |  | June 30,2009
|Stock options                          |  | $                  | 424   |                  | $ | 204          |  | $            | 635   |  | $ | 371  
|Restricted stock                       |  |                    | 20    |                  |   | 6            |  |              | 24    |  |   | 7    
|Performance shares                     |  |                    | 751   |                  |   | 467          |  |              | 1,257 |  |   | 841  
|                                       |  |                    |       |                  |   |              |  |              |       |  |   |      
|Total share-based compensation expense |  | $                  | 1,195 |                  | $ | 677          |  | $            | 1,916 |  | $ | 1,219
|                                       |  |                    |       |                  |   |              |  |              |       |  |   |      

The fair value of the options granted during 2010 was
determined using the Black-Scholes option-pricing model. The assumptions used in the Black-Scholes option-pricing model were as follows:



|                                                        |  |   |         |  
|------------------------------------------------------- |  | - | ------- | -
|Non-qualified stock options                             |  |   |        
|Expected volatility                                     |  |   | 57.5    | %
|Dividend yield                                          |  |   | 3.6     | %
|Risk-free interest rate                                 |  |   | 2.8     | %
|Expected term                                           |  |   | 6 years |  
|Weighted average grant date fair value of stock options |  | $ | 10.46   |  

There were 169,150
options granted with a fair value of $1.7 million on March 11, 2010. These awards are classified as equity awards and vest equally through March 11, 2013. The related compensation expense is based on the date of grant fair value of $25.68
per common share. The compensation expense is amortized on a straight-line basis over the requisite vesting period. For these grants, the Company had chosen a blended volatility which consists of 50% historical volatility average of a peer group and
50% historical volatility of Innophos. The expected term for the stock options is based on the simplified method since the Company has limited data on the exercises of stock options. These stock options qualify as plain vanilla stock
options in accordance with SAB 110. The dividend yield is the expected annual dividend payments divided by the average stock price up to the date of grant. The risk-free interest rates are derived from the U.S. Treasury securities in effect on the
date of grant whose maturity period equals the options expected term. The Company applies an expected forfeiture rate to stock-based compensation expense. The estimate of the forfeiture rate is based primarily upon historical experience of employee
turnover. As actual forfeitures become known, stock-based compensation expense is adjusted accordingly.

There were 79,500
performance shares granted, assuming achieving targeted return on invested capital, on March 11, 2010 with a fair value of $25.68 per common share, or $1.8 million in the aggregate which reflects forfeiture assumptions. The expected term for
the performance shares is a 3 year cliff vesting. Declared dividends will accrue on the performance shares and will vest over the same period. The compensation expense is amortized on a straight-line basis over the requisite vesting period.

4. Inventories:

Inventories consist of the following:



|                  |  |              |         |                  |   |        
|----------------- |  | ------------ | ------- | ---------------- | - | -------
|                  |  | June 30,2010 |         | December 31,2009
|Finished products |  | $            | 73,258  |                  | $ | 73,924 
|Raw materials     |  |              | 35,445  |                  |   | 31,770 
|Spare parts       |  |              | 6,491   |                  |   | 7,942  
|                  |  |              |         |                  |   |        
|                  |  | $            | 115,194 |                  | $ | 113,636
|                  |  |              |         |                  |   |        

Inventory reserves as of June 30, 2010 and
December 31, 2009 were $13,097 and $13,189, respectively.

The Company maintained finished goods, raw material and
packaging inventories at an independently owned and operated warehouse in Nashville, Tennessee. As a result of major flooding in the greater Nashville area during the first few days of May 2010, the warehouse suffered extensive water damage and
has been shut down indefinitely. The inventory value affected by the flood was approximately $3.7 million. The Company has commenced the insurance claims process and currently anticipates that the full amount of the inventory losses will be
recovered. The Company has recorded an insurance receivable of an equal amount.



9



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



5. Other Current Assets:

Other current assets consist of the following:



|                                     |  |              |        |                  |   |       
|------------------------------------ |  | ------------ | ------ | ---------------- | - | ------
|                                     |  | June 30,2010 |        | December 31,2009
|Creditable taxes (value added taxes) |  | $            | 10,816 |                  | $ | 4,028 
|Prepaid income taxes                 |  |              | 16,870 |                  |   | 10,435
|Deferred taxes                       |  |              | 9,650  |                  |   | 11,792
|Prepaids                             |  |              | 9,681  |                  |   | 13,110
|Other                                |  |              | 2,487  |                  |   | 6,273 
|                                     |  |              |        |                  |   |       
|                                     |  | $            | 49,504 |                  | $ | 45,638
|                                     |  |              |        |                  |   |       

6. Intangibles and Other Assets, net:

Intangibles and other assets consist of the following:



|                                                                                                                       |  |                    |  |              |        |                  |   |       
|---------------------------------------------------------------------------------------------------------------------- |  | ------------------ |  | ------------ | ------ | ---------------- | - | ------
|                                                                                                                       |  | Useful life(years) |  | June 30,2010 |        | December 31,2009
|Developed technology and application patents, net of accumulated amortization of $11,112 for 2010 and $10,168 for
2009 |  | 10-20              |  | $            | 25,488 |                  | $ | 26,432
|Customer relationships, net of accumulated amortization of $4,435 for 2010 and $3,961 for 2009                         |  | 5-15               |  |              | 6,895  |                  |   | 7,369 
|Tradenames and license agreements, net of accumulated amortization of $3.608 for 2010 and $3,401 for 2009              |  | 5-20               |  |              | 5,752  |                  |   | 5,959 
|Capitalized software, net of accumulated amortization of $2,600 for 2010 and $2,279 for 2009                           |  | 3-5                |  |              | 266    |                  |   | 700   
|Non-compete agreement, net of accumulated amortization of $378 for 2010 and $315 for 2009                              |  | 5                  |  |              | 252    |                  |   | 315   
|                                                                                                                       |  |                    |  |              |        |                  |   |       
|Total Intangibles                                                                                                      |  |                    |  | $            | 38,653 |                  | $ | 40,775
|                                                                                                                       |  |                    |  |              |        |                  |   |       
|Deferred financing costs, net of accumulated amortization of $7,072 for 2010 and $6,364 for 2009                       |  |                    |  | $            | 5,507  |                  | $ | 6,215 
|Deferred income taxes                                                                                                  |  |                    |  |              | 1,623  |                  |   | 1,409 
|Other assets                                                                                                           |  |                    |  |              | 3,570  |                  |   | 3,084 
|                                                                                                                       |  |                    |  |              |        |                  |   |       
|Total other assets                                                                                                     |  |                    |  | $            | 10,700 |                  | $ | 10,708
|                                                                                                                       |  |                    |  |              |        |                  |   |       
|                                                                                                                       |  |                    |  | $            | 49,353 |                  | $ | 51,483
|                                                                                                                       |  |                    |  |              |        |                  |   |       

7. Other Current Liabilities:

Other current liabilities consist of the following:



|                      |  |              |        |                  |   |       
|--------------------- |  | ------------ | ------ | ---------------- | - | ------
|                      |  | June 30,2010 |        | December 31,2009
|Payroll related       |  |              | 10,512 |                  |   | 6,396 
|Taxes                 |  | $            | 6,808  |                  | $ | 13,480
|Interest              |  |              | 6,411  |                  |   | 8,626 
|Benefits and pensions |  |              | 4,274  |                  |   | 5,104 
|Freight and rebates   |  |              | 2,905  |                  |   | 3,794 
|Legal                 |  |              | 135    |                  |   | 2,820 
|Other                 |  |              | 6,946  |                  |   | 14,383
|                      |  |              |        |                  |   |       
|                      |  | $            | 37,991 |                  | $ | 54,603
|                      |  |              |        |                  |   |       



10



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



8. Debt and Interest:

Short-term borrowings and long-term debt consist of the following:



|                          |  |              |         |                  |   |        
|------------------------- |  | ------------ | ------- | ---------------- | - | -------
|                          |  | June 30,2010 |         | December 31,2009
|Senior subordinated notes |  |              | 190,000 |                  |   | 190,000
|                          |  |              |         |                  |   |        
|                          |  | $            | 190,000 |                  | $ | 190,000
|Less current portion      |  |              |        |                  |   |       
|                          |  |              |         |                  |   |        
|                          |  | $            | 190,000 |                  | $ | 190,000
|                          |  |              |         |                  |   |        

In the second quarter of 2009, the Company and its
wholly owned subsidiary, Innophos Canada, Inc. (the Borrowers) entered into a Loan and Security Agreement (the Loan Agreement) with certain lenders (collectively, the Lenders) including Wachovia Bank, National
Association, as agent.

As of June 30, 2010, the Borrowers had $55.6 million excess availability above the minimum excess
availability requirements, as calculated in accordance with the Loan Agreement, and there was no amount outstanding on the revolving credit line. A total of $1.4 million in face amount of letters of credit are issued under the sub-facility.

In connection with the termination of the 2004 Credit Facility dated as of August 13, 2004 in the second quarter of
2009, the Company paid the $72.7 million of outstanding term loan balance (principal and accrued interest) from cash on hand. This payment resulted in an approximate $0.4 million charge to earnings for the acceleration of deferred financing charges.
Prior to the termination of the term loan, the Company made a $53.6 million excess cash flow payment in the first quarter of 2009 which resulted in an approximate $0.4 million charge to earnings for the acceleration of deferred financing charges.

The Senior Subordinated Notes accrue interest from the issue date at a rate of 8.875% per annum, payable semi-annually
in arrears on February 15 and August 15 of each year.

Holdings Senior Unsecured Notes accrued interest from the
issue date at a rate of 9.5% per annum, payable semi-annually in arrears on April 15 and October 15 of each year. On April 13, 2009 Holdings purchased $10.0 million of the 9.5% Senior Unsecured Notes due April 2012 for $6.5
million. The $3.5 million retirement gain is reflected in interest expense, net in Holdings Consolidated Statement of Operations in the second quarter of 2009. Holdings also recorded accelerated deferred financing costs of approximately $0.2 million
in the second quarter of 2009. These Senior Unsecured Notes were not included in the consolidated results of Innophos, Inc. However, all operations of Holdings are conducted through Innophos, Inc. and therefore, Holdings is dependent on us for debt
servicing and dividend payments through our operations.

Holdings redeemed for cash all remaining $56.0 million of the Senior
Unsecured Notes on April 15, 2010, the Redemption Date. The redemption price for the Notes was 100% of the principal amount plus accrued and unpaid interest to the Redemption Date. Accelerated deferred financing charges of $0.6 million were
recorded in the second quarter of 2010.

As of June 30, 2010, the Company was in full compliance with all debt covenant
requirements.

Total interest cash payments by the Company for all indebtedness for the six months ended June 30, 2010
and June 30, 2009 was $8,699 and $10,259, respectively.

The carrying value and fair value (excluding accrued interest)
of our Senior Subordinated Notes are $190.0 million and $194.8 million at June 30, 2010, respectively.



11



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



Interest expense, net consists of the following:



|                                              |  |                    |       |   |                  |   |       |              |  |   |              |   |  |   |        |  
|--------------------------------------------- |  | ------------------ | ----- | - | ---------------- | - | ----- | ------------ |  | - | ------------ | - |  | - | ------ | -
|                                              |  | Three months ended |       |   | Six months ended |  
|                                              |  | June 30,2010       |       |   | June 30,2009     |   |       | June 30,2010 |  |   | June 30,2009 |  
|Interest expense                              |  | $                  | 4,358 |   |                  |   | 4,738 |              |  | $ | 8,715        |   |  |   | 10,133 |  
|Deferred financing cost                       |  |                    | 354   |   |                  |   | 970   |              |  |   | 708          |   |  |   | 1,934  |  
|Interest income                               |  |                    | (18   | ) |                  |   | (160  | )            |  |   | (144         | ) |  |   | (437   | )
|Less: amount capitalized for capital projects |  |                    | (266  | ) |                  |   | (72   | )            |  |   | (431         | ) |  |   | (89    | )
|                                              |  |                    |       |   |                  |   |       |              |  |   |              |   |  |   |        |  
|Total interest expense, net                   |  | $                  | 4,428 |   |                  | $ | 5,476 |              |  | $ | 8,848        |   |  | $ | 11,541 |  
|                                              |  |                    |       |   |                  |   |       |              |  |   |              |   |  |   |        |  

9. Other Long-term liabilities:

Other long-term liabilities consist of the following:



|                                                               |  |              |        |                  |   |       
|-------------------------------------------------------------- |  | ------------ | ------ | ---------------- | - | ------
|                                                               |  | June 30,2010 |        | December 31,2009
|Environmental liabilities                                      |  | $            | 1,100  |                  |   | 1,100 
|Profit sharing liabilities                                     |  |              | 1,936  |                  |   | 2,350 
|Deferred income taxes                                          |  |              | 18,954 |                  |   | 22,043
|Pension and post retirement liabilities (U.S. and Canada only) |  |              | 4,962  |                  |   | 5,240 
|Other liabilities                                              |  |              | 7,819  |                  |   | 7,187 
|                                                               |  |              |        |                  |   |       
|                                                               |  | $            | 34,771 |                  | $ | 37,920
|                                                               |  |              |        |                  |   |       

10. Income Taxes:

The effective income tax rate on income before taxes was approximately 35% for the six months ended June 30, 2010 compared to
approximately 38% for the comparable period in 2009. The change in the effective tax rate is a result of increased earnings before tax in lower tax jurisdictions combined with a change in tax rates for our operations in multiple tax jurisdictions.
Currently, the Company is under examination by certain foreign jurisdictions for its income tax returns for the years 2004 through 2008. As of June 30, 2010, no significant adjustments have been proposed to the Companys tax positions and
the Company currently does not anticipate any adjustments that would result in a material change to its financial position.

The Company is included in a consolidated U.S. tax return of Innophos Holdings, Inc., however the income tax provision has been prepared
on a separate return basis. The Mexican subsidiaries file separate tax returns and current income taxes receivable or payable are reflected on the accompanying combined balance sheets.

Income taxes paid were $23,319 and $37,565 for the six months ended June 30, 2010 and June 30, 2009, respectively.

11. Commitments and Contingencies

Environmental

The Companys operations are subject to extensive and changing federal and state environmental laws and regulations. The
Companys manufacturing sites have an extended history of industrial use, and soil and groundwater contamination have or may have occurred in the past and might occur or be discovered in the future.

Environmental efforts are difficult to assess for numerous reasons, including the discovery of new remedial sites, discovery of new
information and scarcity of reliable information pertaining to certain sites, improvements in technology, changes in environmental laws and regulations, numerous possible remedial techniques and solutions, difficulty in assessing the involvement of
and the financial capability of other potentially responsible parties and the extended time periods over which remediation occurs. Other than the items listed below, the Company is not aware of material environmental liabilities which are probable
and estimable. As the Companys environmental contingencies are more clearly determined, it is reasonably possible that amounts may need to be accrued. However, management does not believe, based on current information, that environmental
remediation requirements will have a material impact on the Companys results of operations, financial position or cash flows.

Under the agreements by which the Company acquired the Phosphates Business and related assets, the Company has certain rights of
indemnification from the sellers for breach of representations, warranties, covenants and other agreements. The indemnification rights relating to undisclosed environmental matters are subject to certain substantial limitations and exclusions and
expired as of August 13, 2009.



12



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



Future environmental spending is probable at our site in Nashville, TN, the eastern
portion of which had been used historically as a landfill, and a western parcel previously acquired from a third party, which reportedly had housed, but no longer does, a fertilizer and pesticide manufacturing facility. We have an estimated
liability with a range of $0.9-$1.2 million. The remedial action plan has yet to be finalized, and as such, the Company has recorded a liability, which represents the Companys best estimate, of $1.1 million as of June 30, 2010.

The U.S. Environmental Protection Agency, or EPA, has indicated that compliance at facilities in the phosphate industry is a
high enforcement priority. After several years of expressing various concerns (without issuing any notice of violation) about aspects of our Geismar, LA operations, in March 2008, we received a letter from the Department of Justice, or DOJ,
indicating that EPA had referred the case for civil enforcement, contending, among other things, that we do not qualify for certain exemptions we have claimed, and alleging that we violate the Resource Conservation and Recovery Act (RCRA) at Geismar
by failing to manage two materials appropriately. Although the letter stated that EPA/DOJ intended to seek unspecified penalties and corrective action, it proposed discussions to explore possible resolution, which we undertook and are pursuing.
During the fourth quarter of 2008, the DOJ/EPA demanded that Innophos and its neighboring interconnected supplier, PCS, undertake certain interim measures to address DOJ/EPAs chief environmental concerns. We and PCS have initiated
joint technical efforts to explore solutions to the government concerns. Based on our contact with the agencies to date, we have determined it is probable that one of the process modifications will need to be undertaken in the near term, and
likewise probable that the capital expenditure and future operating expense of that modification will not be material, unless the DOJ adds terms and conditions that could result in the parties not reaching agreement. However, the second measure
sought by DOJ/EPA has not yet been fully evaluated from a technological or cost standpoint. The companies have proposed to DOJ/EPA a schedule for such evaluation, and although the government has not formally approved the schedule, the companies are
proceeding as proposed. Based upon work so far, there appears to be at least one technically viable approach, but both detailed costing and other approaches need to be evaluated. Even though the companies have begun substantial technical work in an
attempt to develop a feasible approach to address DOJ/EPAs concerns, we cannot guarantee that our technical efforts will be successful, whether either party would be willing to implement solutions or, depending on those factors and the
agencies position, whether this matter will be settled with DOJ/EPA or will require litigation. Should litigation become necessary to defend our operations at Geismar as compliant with environmental laws and regulations, no assurance can be
given as to its outcome. We have determined that a contingent liability is neither probable nor estimable at this time, but liability is reasonably possible.

Litigation

Mexican CNA Water Tax Claims

Nature and Extent.In November 2004, our Mexican subsidiary, Innophos Fosfatados, or Fosfatados, received notice from the CNA of
the Fresh Water Claims relating to water usage at our Coatzacoalcos, Veracruz, Mexico plant. As initially assessed, the claims extended from 1998-2002, but subsequently the 1998 claim was determined to be beyond the applicable statute of
limitations. As now assessed, the claims through 2002 total approximately $23.8 million (at current exchange rates), including basic charges of $7.1 million and $16.7 million for interest, inflation and penalties. Management believes that Fosfatados
has valid bases for challenging the Fresh Water Claims, and that matter is being defended vigorously.

Rhodia Indemnity
Confirmed.As a result of favorably concluded litigation in New York state courts against Rhodia, S.A. and affiliates, or the New York Litigation, concerning their indemnification obligation for CNA claims as taxes under the
agreement by which we purchased our business from those parties, Innophos is fully indemnified against the Fresh Water Claims, as well as any like claims pertaining to periods prior to the closing date of purchase, August 13, 2004, were such
liabilities to be sustained.

Further Proceedings.The Fresh Water Claims are currently pending reconsideration from
appeals in the Mexican fiscal court system. Following a May 25, 2010 unfavorable ruling by the intermediate appellate court as to Fosfatados substantive defenses and its favorable ruling as to 1998 being beyond the applicable statute of
limitations, on June 8, 2010, Fosfatados appealed the unfavorable rulings to the Supreme Court of Mexico. The timing of a decision on this round of appeals is not known.

A final determination of the Fresh Water Claims may require remands to the CNA or to lower courts. In the event that the appeals were to
be decided against us and Rhodia were then unable to pay on its indemnification obligations, our subsidiary could be required to satisfy a judgment for the entire amount claimed.

Possible Post-2002 Claims.If the CNA Fresh Water Claims were sustained for the period now at issue, it is possible that the CNA
would seek to claim similar higher duties, fees and other charges for fresh water extraction and usage from 2005 on into the future (2003 and 2004 are believed to be beyond the statute of limitations), or the Post-2002 Fresh Water Claims. Management
estimates that amounts involved would be approximately $6.5 million of additional basic charges to date at current exchange rates,

$6.9
million relating to interest, inflation, and penalties, and, under current operating conditions, approximately $1.6 million of additional basic charges per year at current exchange rates.



13



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



On June 28, 2010, Fosfatados received a CNA notice of audit and request for
documents concerning fresh water usage for the period 2005-2009. Although not included in our court judgments in the New York Litigation against Rhodia, we believe Rhodia is required to indemnify us fully for post-closing losses caused
by breaches of covenants set forth in the agreement, which could represent the remainder of the Post-2002 Fresh Water Claims exposure. Rhodia has contested indemnification responsibility for those breaches, but its motion for partial summary
judgment to dismiss our claims was denied by the New York trial court in January 2009. It is possible that the New York Litigation will proceed to trial or involve further motions to resolve remaining issues. Upon receipt of the new CNA notice we
renewed our claim for indemnification by Rhodia, which was declined. Fosfatados is defending the matter.

Based upon advice of
counsel and our review of the CNA Fresh Water Claims and the Post-2002 Fresh Water Claims, the facts and applicable law, management has determined that liability is reasonably possible, but is neither probable nor reasonably estimable. Accordingly,
we did not establish a liability on the balance sheet as of June 30, 2010. As additional information is gained, management will reassess the potential liability and establish any loss reserve as appropriate. The ultimate liability amount could
be material to our results of operations and financial condition.

Even though our indemnification rights have been confirmed
by court judgments, ultimately we are also dependent on Rhodia having sufficient financial capacity to meet its obligations should they arise. Rhodias financial position has improved significantly in recent quarters and we currently see no
reason to suspect they would be unable to meet their obligations.

Other Legal Matters

In June 2005, our subsidiary, Innophos Canada, Inc., was contacted by representatives of The Mosaic Company (a division of Cargill
Corporation), or Mosaic, seeking a meeting to discuss the status of an ongoing remedial investigation and clean-up Mosaic is conducting at its former fertilizer manufacturing site located north of Innophos Pt. Maitland, Ontario, Canada plant
site. The remediation is being overseen by the Provincial Ministry of Environment, or MOE. Mosaic stated that, in its view, we and Rhodia (our predecessor in interest prior to August 2004) were responsible for some phosphorus compound contamination
at a rail yard between the Innophos and Mosaic sites, and will be asked to participate in the clean-up. We have determined that this contingent liability is neither probable nor estimable at this time, but liability is reasonably possible. We have
notified Rhodia of the Mosaic claim, and we will seek all appropriate indemnification.

In March 2008, Sudamfos S.A., or
Sudamfos, an Argentine phosphate producer, filed a request for arbitration before the ICC International Court of Arbitration, Paris, France, or ICC, of a commercial dispute with Mexicana. Sudamfos claimed Mexicana agreed to sell Sudamfos certain
quantities of phosphoric acid for delivery in 2007 and 2008, and sought an order requiring Mexicana to sell approximately 12,500 metric tons during 2008 in accordance with the claimed agreement. Subsequently, Sudamfos withdrew the request for
arbitration. In October 2008, Mexicana filed a lawsuit in Mexico against Sudamfos to collect approximately $1.2 million representing the contract price for prior deliveries of acid that Sudamfos had refused to pay. In October 2009, Sudamfos answered
the suit and counterclaimed for $3.0 million based upon the agreement alleged in the arbitration request to sell additional acid, which agreement Mexicana denies. In June 2010, Mexicos trial court ruled in favor of Mexicanas claim and
denied Sudamfoss counterclaim. In July 2010, Sudamfos appealed that ruling. The timing of a decision on the appeal is not known. Management has determined that the outstanding receivable is fully collectible, and that the contingent liability
from the Sudamfos counterclaim is remote, and therefore no accrual is required.

In addition, we are party to legal
proceedings and contractual disputes that arise in the ordinary course of our business. Except as to the matters specifically discussed, management does not believe that these matters represent probable liabilities. However, these matters cannot be
predicted with certainty and an unfavorable resolution of one or more of them could have a material adverse effect on our business, results of operations, financial condition, and/or cash flows.



14



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



12. Pension:

Net periodic benefit expense for the United States plans for the three months ended June 30, 2010:



|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|------------------------------------------- |  | --------------- | --- | - | ------------- | - | --- | ----- |  | - | --- | -
|                                            |  | 2010            |    
|                                            |  | Pensionbenefits |     |   | Otherbenefits |   |     | Total | 
|Service cost                                |  | $               |    |   |               | $ | 90  |       |  | $ | 90  |  
|Interest cost                               |  |                 | 28  |   |               |   | 46  |       |  |   | 74  |  
|Expected return on assets                   |  |                 | (21 | ) |               |   |    |       |  |   | (21 | )
|Amortization of prior service cost          |  |                 |    |   |               |   | 66  |       |  |   | 66  |  
|Amortization of unrecognized (gains)/losses |  |                 | (1  | ) |               |   | (20 | )     |  |   | (21 | )
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|Net periodic benefit expense                |  | $               | 6   |   |               | $ | 182 |       |  | $ | 188 |  
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  

Net periodic benefit expense for the United States plans for the three months ended June 30, 2009:



|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|------------------------------------------- |  | --------------- | --- | - | ------------- | - | --- | ----- |  | - | --- | -
|                                            |  | 2009            |    
|                                            |  | Pensionbenefits |     |   | Otherbenefits |   |     | Total | 
|Service cost                                |  | $               |    |   |               | $ | 88  |       |  | $ | 88  |  
|Interest cost                               |  |                 | 26  |   |               |   | 40  |       |  |   | 66  |  
|Expected return on assets                   |  |                 | (24 | ) |               |   |    |       |  |   | (24 | )
|Amortization of prior service cost          |  |                 |    |   |               |   | 66  |       |  |   | 66  |  
|Amortization of unrecognized (gains)/losses |  |                 |    |   |               |   | (21 | )     |  |   | (21 | )
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|Net periodic benefit expense                |  | $               | 2   |   |               | $ | 173 |       |  | $ | 175 |  
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  

Net periodic benefit expense for the United States plans for the six months ended June 30, 2010:



|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|------------------------------------------- |  | --------------- | --- | - | ------------- | - | --- | ----- |  | - | --- | -
|                                            |  | 2010            |    
|                                            |  | Pensionbenefits |     |   | Otherbenefits |   |     | Total | 
|Service cost                                |  | $               |    |   |               | $ | 180 |       |  | $ | 180 |  
|Interest cost                               |  |                 | 55  |   |               |   | 92  |       |  |   | 147 |  
|Expected return on assets                   |  |                 | (42 | ) |               |   |    |       |  |   | (42 | )
|Amortization of prior service cost          |  |                 |    |   |               |   | 131 |       |  |   | 131 |  
|Amortization of unrecognized (gains)/losses |  |                 | (2  | ) |               |   | (39 | )     |  |   | (41 | )
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|Net periodic benefit expense                |  | $               | 11  |   |               | $ | 364 |       |  | $ | 375 |  
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  

Net periodic benefit expense for the United States plans for the six months ended June 30, 2009:



|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|------------------------------------------- |  | --------------- | --- | - | ------------- | - | --- | ----- |  | - | --- | -
|                                            |  | 2009            |    
|                                            |  | Pensionbenefits |     |   | Otherbenefits |   |     | Total | 
|Service cost                                |  | $               |    |   |               | $ | 176 |       |  | $ | 176 |  
|Interest cost                               |  |                 | 52  |   |               |   | 81  |       |  |   | 133 |  
|Expected return on assets                   |  |                 | (48 | ) |               |   |    |       |  |   | (48 | )
|Amortization of prior service cost          |  |                 |    |   |               |   | 131 |       |  |   | 131 |  
|Amortization of unrecognized (gains)/losses |  |                 |    |   |               |   | (42 | )     |  |   | (42 | )
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  
|Net periodic benefit expense                |  | $               | 4   |   |               | $ | 346 |       |  | $ | 350 |  
|                                            |  |                 |     |   |               |   |     |       |  |   |     |  

We made our entire cash contributions of $2.6 million for our U.S. defined contribution plan during the
first quarter of 2010 for the plan year 2009. The U.S. defined benefit cash contributions will be, at a minimum, approximately $0.1 million for 2010 which payment was made in the second quarter of 2010.



15



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



Net periodic benefit expense for the Canadian plans for the three months ended
June 30, 2010:



|                                            |  |                 |      |   |               |   |     |       |  |   |      |  
|------------------------------------------- |  | --------------- | ---- | - | ------------- | - | --- | ----- |  | - | ---- | -
|                                            |  | 2010            |     
|                                            |  | Pensionbenefits |      |   | Otherbenefits |   |     | Total | 
|Service cost                                |  | $               | 53   |   |               | $ | 14  |       |  | $ | 67   |  
|Interest cost                               |  |                 | 138  |   |               |   | 22  |       |  |   | 160  |  
|Expected return on assets                   |  |                 | (219 | ) |               |   |    |       |  |   | (219 | )
|Amortization of transition obligation       |  |                 |     |   |               |   |    |       |  |   |     |  
|Amortization of prior service cost          |  |                 | 21   |   |               |   | 3   |       |  |   | 24   |  
|Amortization of unrecognized (gains)/losses |  |                 | 28   |   |               |   | 10  |       |  |   | 38   |  
|Exchange rate changes                       |  |                 | 74   |   |               |   | (16 | )     |  |   | 58   |  
|                                            |  |                 |      |   |               |   |     |       |  |   |      |  
|Net periodic benefit expense                |  | $               | 95   |   |               | $ | 33  |       |  | $ | 128  |  
|                                            |  |                 |      |   |               |   |     |       |  |   |      |  

Net periodic benefit expense for the Canadian plans for the three months ended June 30, 2009:



|                                            |  |                 |      |   |               |   |       |  |   |      |  
|------------------------------------------- |  | --------------- | ---- | - | ------------- | - | ----- |  | - | ---- | -
|                                            |  | 2009            |     
|                                            |  | Pensionbenefits |      |   | Otherbenefits |   | Total | 
|Service cost                                |  | $               | 36   |   |               | $ | 10    |  | $ | 46   |  
|Interest cost                               |  |                 | 110  |   |               |   | 16    |  |   | 126  |  
|Expected return on assets                   |  |                 | (147 | ) |               |   |      |  |   | (147 | )
|Amortization of transition obligation       |  |                 |     |   |               |   | 6     |  |   | 6    |  
|Amortization of prior service cost          |  |                 | 4    |   |               |   |      |  |   | 4    |  
|Amortization of unrecognized (gains)/losses |  |                 | 19   |   |               |   | 1     |  |   | 20   |  
|Exchange rate changes                       |  |                 | (235 | ) |               |   | 73    |  |   | (162 | )
|                                            |  |                 |      |   |               |   |       |  |   |      |  
|Net periodic benefit expense                |  | $               | (213 | ) |               | $ | 106   |  | $ | (107 | )
|                                            |  |                 |      |   |               |   |       |  |   |      |  

Net periodic benefit expense for the Canadian plans for the six months ended June 30, 2010:



|                                            |  |                 |      |   |               |   |    |       |  |   |      |  
|------------------------------------------- |  | --------------- | ---- | - | ------------- | - | -- | ----- |  | - | ---- | -
|                                            |  | 2010            |     
|                                            |  | Pensionbenefits |      |   | Otherbenefits |   |    | Total | 
|Service cost                                |  | $               | 105  |   |               | $ | 27 |       |  | $ | 132  |  
|Interest cost                               |  |                 | 271  |   |               |   | 43 |       |  |   | 314  |  
|Expected return on assets                   |  |                 | (431 | ) |               |   |   |       |  |   | (431 | )
|Amortization of transition obligation       |  |                 |     |   |               |   |   |       |  |   |     |  
|Amortization of prior service cost          |  |                 | 46   |   |               |   | 10 |       |  |   | 56   |  
|Amortization of unrecognized (gains)/losses |  |                 | 51   |   |               |   | 15 |       |  |   | 66   |  
|Exchange rate changes                       |  |                 | (5   | ) |               |   | (1 | )     |  |   | (6   | )
|                                            |  |                 |      |   |               |   |    |       |  |   |      |  
|Net periodic benefit expense                |  | $               | 37   |   |               | $ | 94 |       |  | $ | 131  |  
|                                            |  |                 |      |   |               |   |    |       |  |   |      |  

Net periodic benefit expense for the Canadian plans for the six months ended June 30, 2009:



|                                            |  |                 |      |   |               |   |       |  |   |      |  
|------------------------------------------- |  | --------------- | ---- | - | ------------- | - | ----- |  | - | ---- | -
|                                            |  | 2009            |     
|                                            |  | Pensionbenefits |      |   | Otherbenefits |   | Total | 
|Service cost                                |  | $               | 73   |   |               | $ | 19    |  | $ | 92   |  
|Interest cost                               |  |                 | 220  |   |               |   | 33    |  |   | 253  |  
|Expected return on assets                   |  |                 | (294 | ) |               |   |      |  |   | (294 | )
|Amortization of transition obligation       |  |                 |     |   |               |   | 12    |  |   | 12   |  
|Amortization of prior service cost          |  |                 | 8    |   |               |   |      |  |   | 8    |  
|Amortization of unrecognized (gains)/losses |  |                 | 38   |   |               |   | 2     |  |   | 40   |  
|Exchange rate changes                       |  |                 | (173 | ) |               |   | 53    |  |   | (120 | )
|                                            |  |                 |      |   |               |   |       |  |   |      |  
|Net periodic benefit expense                |  | $               | (128 | ) |               | $ | 119   |  | $ | (9   | )
|                                            |  |                 |      |   |               |   |       |  |   |      |  

We made cash contributions to our Canadian defined benefit plan of $0.5 million during the six months
ended June 30, 2010. We expect to make additional cash contributions to our Canadian defined benefit plans of $0.5 million during the remainder of 2010.



16



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



13. Segment Reporting:

The Company discloses certain financial and supplementary information about its reportable segments, revenue by products and revenues by
geographic area. Operating segments are defined as components of an enterprise about which separate discrete financial information is evaluated regularly by the chief operating decision maker, in order to decide how to allocate resources and assess
performance. The primary key performance indicators for the chief operating decision maker are Sales and Operating Income.

Beginning with the second quarter, the Company realigned the reportable segments to better reflect the core businesses in which Innophos
operates and how it is managed. The Company will report its core specialty phosphates business separately from GTSP and other non-specialty phosphate products. The previous reported segments of the United States, Mexico and Canada changed to
Specialty Phosphates US & Canada, Specialty Phosphates Mexico and GTSP & Other. Specialty phosphates consists of the products lines Specialty Salts and Specialty Acids, Food & Technical Grade Acid, and STPP &
Detergent Grade Acid. GTSP & Other includes fertilizer co-product GTSP and other non-specialty phosphate products. The Company has restated all corresponding items of segment information for earlier periods. Total asset changes were
immaterial from the amounts disclosed in the last annual report.



|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|---------------------------------------- |  | ------------------------------ | ------- | ------------------------- | - | ------------ |  | - | ------------ | - |  | ----- | ------- | - |  | - | -------
|For the three months ended June 30, 2010 |  | SpecialtyPhosphatesUS & Canada |         | SpecialtyPhosphatesMexico |   | GTSP & Other |  |   | Eliminations |   |  | Total
|Sales                                    |  | $                              | 123,086 |                           | $ | 39,298       |  | $ | 21,648       |   |  | $     |         |   |  | $ | 184,032
|Intersegment sales                       |  |                                | 372     |                           |   | 12,854       |  |   | 45           |   |  |       | (13,271 | ) |  |   |       
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Total sales                              |  | $                              | 123,458 |                           | $ | 52,152       |  | $ | 21,693       |   |  | $     | (13,271 | ) |  | $ | 184,032
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Operating income                         |  | $                              | 26,758  |                           | $ | 4,011        |  | $ | 1,908        |   |  | $     |        |   |  | $ | 32,677 
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Depreciation expense                     |  | $                              | 7,060   |                           | $ | 3,957        |  | $ | 1,243        |   |  | $     |        |   |  | $ | 12,260 
|                                         |  |                                |         |                           |  
|For the three months ended June 30, 2009 |  | SpecialtyPhosphatesUS & Canada |         | SpecialtyPhosphatesMexico |   | GTSP & Other |  |   | Eliminations |   |  | Total
|Sales                                    |  | $                              | 127,098 |                           | $ | 34,000       |  | $ | 5,668        |   |  | $     |        |   |  | $ | 166,766
|Intersegment sales                       |  |                                | 9,428   |                           |   | 2,878        |  |   | 106          |   |  |       | (12,412 | ) |  |   |       
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Total sales                              |  | $                              | 136,526 |                           | $ | 36,878       |  | $ | 5,774        |   |  | $     | (12,412 | ) |  | $ | 166,766
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Operating income                         |  | $                              | 33,024  |                           | $ | 5,778        |  | $ | (7,364       | ) |  | $     |        |   |  | $ | 31,438 
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Depreciation and amortization expense    |  | $                              | 7,217   |                           | $ | 3,707        |  | $ | 1,328        |   |  | $     |        |   |  | $ | 12,252 
|                                         |  |                                |         |                           |  
|For the six months ended June 30, 2010   |  | SpecialtyPhosphatesUS & Canada |         | SpecialtyPhosphatesMexico |   | GTSP & Other |  |   | Eliminations |   |  | Total
|Sales                                    |  | $                              | 246,444 |                           | $ | 72,497       |  | $ | 34,098       |   |  | $     |        |   |  | $ | 353,039
|Intersegment sales                       |  |                                | 1,568   |                           |   | 22,037       |  |   | 92           |   |  |       | (23,697 | ) |  |   |       
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Total sales                              |  | $                              | 248,012 |                           | $ | 94,534       |  | $ | 34,190       |   |  | $     | (23,697 | ) |  | $ | 353,039
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Operating income                         |  | $                              | 46,819  |                           | $ | 5,434        |  | $ | 2,049        |   |  | $     |        |   |  | $ | 54,302 
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Depreciation expense                     |  | $                              | 14,485  |                           | $ | 7,854        |  | $ | 2,575        |   |  | $     |        |   |  | $ | 24,914 
|                                         |  |                                |         |                           |  
|For the six months ended June 30, 2009   |  | SpecialtyPhosphatesUS & Canada |         | SpecialtyPhosphatesMexico |   | GTSP & Other |  |   | Eliminations |   |  | Total
|Sales                                    |  | $                              | 259,488 |                           | $ | 74,781       |  | $ | 23,314       |   |  | $     |        |   |  | $ | 357,583
|Intersegment sales                       |  |                                | 11,085  |                           |   | 3,534        |  |   | 153          |   |  |       | (14,772 | ) |  |   |       
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Total sales                              |  | $                              | 270,573 |                           | $ | 78,315       |  | $ | 23,467       |   |  | $     | (14,772 | ) |  | $ | 357,583
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Operating income                         |  | $                              | 80,795  |                           | $ | 14,938       |  | $ | (9,007       | ) |  | $     |        |   |  | $ | 86,726 
|                                         |  |                                |         |                           |   |              |  |   |              |   |  |       |         |   |  |   |        
|Depreciation and amortization expense    |  | $                              | 13,859  |                           | $ | 8,045        |  | $ | 1,944        |   |  | $     |        |   |  | $ | 23,848 



17



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



14. Condensed Combining Financial Statements:

The following condensed combined financial data is presented to segregate the assets, liabilities, and results of operations and cash
flows of the US operations (the Guarantors) and the Canadian and Mexican operations (the Non-guarantors). Innophos Inc. has issued debt and the Guarantor subsidiary is a 100% wholly owned subsidiary of Innophos Inc. The
Non-guarantors are 100% wholly-owned subsidiaries of the Guarantors. Innophos, Inc. and the Guarantor subsidiary will fully and unconditionally and jointly and severally, guarantee the Companys obligations under the Companys Senior
Subordinated Notes due 2014. Investments in subsidiaries are accounted for by the guarantor using the equity method of accounting. The Non-guarantors are presented on a combined basis. The principal combining adjustments are to eliminate
intercompany balances and transactions.

INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheet

As of June 30, 2010

(In thousands)



|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|------------------------------------ |  | -------------- | ------- | ------------------- | - | ----------------------- |  | -------------------------- | ------- |  | ----- | ---------- | - |  | - | -------
|                                     |  | Innophos, Inc. |         | GuarantorSubsidiary |   | Non-GuarantorSubsidiary |  | AdjustmentsandEliminations |         |  | Total
|ASSETS                               |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Current Assets:                      |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Cash and cash equivalents            |  | $              | 23,556  |                     | $ | 1                       |  | $                          | 43,110  |  | $     |           |   |  | $ | 66,667 
|Accounts receivable, net             |  |                | 329,385 |                     |   |                        |  |                            | 303,782 |  |       | (554,360   | ) |  |   | 78,807 
|Inventories                          |  |                | 54,858  |                     |   |                        |  |                            | 60,336  |  |       |           |   |  |   | 115,194
|Other current assets                 |  |                | 23,376  |                     |   |                        |  |                            | 26,211  |  |       | (83        | ) |  |   | 49,504 
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Total current assets                 |  |                | 431,175 |                     |   | 1                       |  |                            | 433,439 |  |       | (554,443   | ) |  |   | 310,172
|Property, plant and equipment, net   |  |                | 99,633  |                     |   |                        |  |                            | 97,009  |  |       |           |   |  |   | 196,642
|Goodwill                             |  |                | 7,237   |                     |   |                        |  |                            | 44,469  |  |       |           |   |  |   | 51,706 
|Investment in subsidiaries           |  |                | 245,581 |                     |   | 193,437                 |  |                            |        |  |       | (439,018   | ) |  |   |       
|Intercompany notes                   |  |                | 30,135  |                     |   |                        |  |                            |        |  |       | (30,135    | ) |  |   |       
|Intangibles and other assets, net    |  |                | 35,828  |                     |   |                        |  |                            | 13,525  |  |       |           |   |  |   | 49,353 
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Total                                |  | $              | 849,589 |                     | $ | 193,438                 |  | $                          | 588,442 |  | $     | (1,023,596 | ) |  | $ | 607,873
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|LIABILITIES AND STOCKHOLDERS EQUITY |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Current Liabilities:                 |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Current portion of long-term debt    |  | $              |        |                     | $ |                        |  | $                          |        |  | $     |           |   |  | $ |       
|Accounts payable, trade and other    |  |                | 303,450 |                     |   |                        |  |                            | 284,001 |  |       | (554,360   | ) |  |   | 33,091 
|Other current liabilities            |  |                | 26,871  |                     |   |                        |  |                            | 11,203  |  |       | (83        | ) |  |   | 37,991 
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Total current liabilities            |  |                | 330,321 |                     |   |                        |  |                            | 295,204 |  |       | (554,443   | ) |  |   | 71,082 
|Long-term debt                       |  |                | 190,000 |                     |   |                        |  |                            | 30,135  |  |       | (30,135    | ) |  |   | 190,000
|Other long-term liabilities          |  |                | 17,249  |                     |   |                        |  |                            | 17,522  |  |       |           |   |  |   | 34,771 
|Total stockholders equity           |  |                | 312,019 |                     |   | 193,438                 |  |                            | 245,581 |  |       | (439,018   | ) |  |   | 312,020
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        
|Total                                |  | $              | 849,589 |                     | $ | 193,438                 |  | $                          | 588,442 |  | $     | (1,023,596 | ) |  | $ | 607,873
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |            |   |  |   |        



18



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheet

As of December 31, 2009

(In thousands)



|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|------------------------------------ |  | -------------- | ------- | ------------------- | - | ----------------------- |  | -------------------------- | ------- |  | ----- | -------- | - |  | - | -------
|                                     |  | Innophos, Inc. |         | GuarantorSubsidiary |   | Non-GuarantorSubsidiary |  | AdjustmentsandEliminations |         |  | Total
|ASSETS                               |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Current Assets:                      |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Cash and cash equivalents            |  | $              | 72,079  |                     | $ | 2                       |  | $                          | 60,141  |  | $     |         |   |  | $ | 132,222
|Restricted cash                      |  |                |        |                     |   |                        |  |                            | 1,749   |  |       |         |   |  |   | 1,749  
|Accounts receivable, net             |  |                | 285,306 |                     |   |                        |  |                            | 264,519 |  |       | (493,480 | ) |  |   | 56,345 
|Inventories                          |  |                | 62,552  |                     |   |                        |  |                            | 51,084  |  |       |         |   |  |   | 113,636
|Other current assets                 |  |                | 27,395  |                     |   |                        |  |                            | 18,327  |  |       | (84      | ) |  |   | 45,638 
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Total current assets                 |  |                | 447,332 |                     |   | 2                       |  |                            | 395,820 |  |       | (493,564 | ) |  |   | 349,590
|Property, plant and equipment, net   |  |                | 99,844  |                     |   |                        |  |                            | 104,683 |  |       |         |   |  |   | 204,527
|Goodwill                             |  |                | 7,237   |                     |   |                        |  |                            | 44,469  |  |       |         |   |  |   | 51,706 
|Investment in subsidiaries           |  |                | 238,013 |                     |   | 188,623                 |  |                            |        |  |       | (426,636 | ) |  |   |       
|Intercompany notes                   |  |                | 29,642  |                     |   |                        |  |                            |        |  |       | (29,642  | ) |  |   |       
|Intangibles and other assets, net    |  |                | 38,345  |                     |   |                        |  |                            | 13,138  |  |       |         |   |  |   | 51,483 
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Total                                |  | $              | 860,413 |                     | $ | 188,625                 |  | $                          | 558,110 |  | $     | (949,842 | ) |  | $ | 657,306
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|LIABILITIES AND STOCKHOLDERS EQUITY |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Current liabilities:                 |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Current portion of long-term debt    |  | $              |        |                     | $ |                        |  | $                          |        |  | $     |         |   |  | $ |       
|Accounts payable, trade and other    |  |                | 276,150 |                     |   |                        |  |                            | 249,910 |  |       | (493,480 | ) |  |   | 32,580 
|Other current liabilities            |  |                | 33,149  |                     |   |                        |  |                            | 21,538  |  |       | (84      | ) |  |   | 54,603 
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Total current liabilities            |  |                | 309,299 |                     |   |                        |  |                            | 271,448 |  |       | (493,564 | ) |  |   | 87,183 
|Long-term debt                       |  |                | 190,000 |                     |   |                        |  |                            | 29,642  |  |       | (29,642  | ) |  |   | 190,000
|Other long-term liabilities          |  |                | 18,911  |                     |   |                        |  |                            | 19,009  |  |       |         |   |  |   | 37,920 
|Total stockholders equity           |  |                | 342,203 |                     |   | 188,625                 |  |                            | 238,011 |  |       | (426,636 | ) |  |   | 342,203
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        
|Total                                |  | $              | 860,413 |                     | $ | 188,625                 |  | $                          | 558,110 |  | $     | (949,842 | ) |  | $ | 657,306
|                                     |  |                |         |                     |   |                         |  |                            |         |  |       |          |   |  |   |        

INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Operations

For the three months ended June 30, 2010

(In thousands)



|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|----------------------------------- |  | -------------- | ------- | - | ------------------- | - | ------ | ----------------------- |  | -------------------------- | ------ |  | ----- | ------- | - |  | - | -------
|                                    |  | Innophos, Inc. |         |   | GuarantorSubsidiary |   |        | Non-GuarantorSubsidiary |  | AdjustmentsandEliminations |        |  | Total
|Net Sales                           |  | $              | 119,590 |   |                     | $ |       |                         |  | $                          | 97,818 |  | $     | (33,376 | ) |  | $ | 184,032
|Cost of goods sold                  |  |                | 83,394  |   |                     |   |       |                         |  |                            | 86,953 |  |       | (33,376 | ) |  |   | 136,971
|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|Gross Profit                        |  |                | 36,196  |   |                     |   |       |                         |  |                            | 10,865 |  |       |        |   |  |   | 47,061 
|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|Operating expenses:                 |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|Selling, general and administrative |  |                | 11,042  |   |                     |   | 1      |                         |  |                            | 2,727  |  |       |        |   |  |   | 13,770 
|Research & development expenses     |  |                | 614     |   |                     |   |       |                         |  |                            |       |  |       |        |   |  |   | 614    
|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|Total operating expenses            |  |                | 11,656  |   |                     |   | 1      |                         |  |                            | 2,727  |  |       |        |   |  |   | 14,384 
|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|Operating income                    |  |                | 24,540  |   |                     |   | (1     | )                       |  |                            | 8,138  |  |       |        |   |  |   | 32,677 
|Interest expense, net               |  |                | 4,156   |   |                     |   |       |                         |  |                            | 272    |  |       |        |   |  |   | 4,428  
|Foreign exchange gains              |  |                | 193     |   |                     |   |       |                         |  |                            | 518    |  |       |        |   |  |   | 711    
|Equity (income) loss                |  |                | (5,208  | ) |                     |   | (3,840 | )                       |  |                            |       |  |       | 9,048   |   |  |   |       
|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|Income (loss) before income tax     |  |                | 25,399  |   |                     |   | 3,839  |                         |  |                            | 7,348  |  |       | (9,048  | ) |  |   | 27,538 
|Provision for income taxes          |  |                | 7,077   |   |                     |   |       |                         |  |                            | 2,139  |  |       |        |   |  |   | 9,216  
|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        
|Net income (loss)                   |  | $              | 18,322  |   |                     | $ | 3,839  |                         |  | $                          | 5,209  |  | $     | (9,048  | ) |  | $ | 18,322 
|                                    |  |                |         |   |                     |   |        |                         |  |                            |        |  |       |         |   |  |   |        



19



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Operations

For the six months ended June 30, 2010

(In thousands)



|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|----------------------------------- |  | -------------- | ------- | - | ------------------- | - | ------ | ----------------------- |  | -------------------------- | ------- |  | ----- | ------- | - |  | - | -------
|                                    |  | Innophos, Inc. |         |   | GuarantorSubsidiary |   |        | Non-GuarantorSubsidiary |  | AdjustmentsandEliminations |         |  | Total
|Net Sales                           |  | $              | 243,560 |   |                     | $ |       |                         |  | $                          | 179,661 |  | $     | (70,182 | ) |  | $ | 353,039
|Cost of goods sold                  |  |                | 178,210 |   |                     |   |       |                         |  |                            | 161,244 |  |       | (70,182 | ) |  |   | 269,272
|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|Gross Profit                        |  |                | 65,350  |   |                     |   |       |                         |  |                            | 18,417  |  |       |        |   |  |   | 83,767 
|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|Operating expenses:                 |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|Selling, general and administrative |  |                | 21,271  |   |                     |   | 1      |                         |  |                            | 7,016   |  |       |        |   |  |   | 28,288 
|Research & development expenses     |  |                | 1,177   |   |                     |   |       |                         |  |                            |        |  |       |        |   |  |   | 1,177  
|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|Total operating expenses            |  |                | 22,448  |   |                     |   | 1      |                         |  |                            | 7,016   |  |       |        |   |  |   | 29,465 
|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|Operating income                    |  |                | 42,902  |   |                     |   | (1     | )                       |  |                            | 11,401  |  |       |        |   |  |   | 54,302 
|Interest expense, net               |  |                | 8,420   |   |                     |   |       |                         |  |                            | 428     |  |       |        |   |  |   | 8,848  
|Foreign exchange (gains) losses     |  |                | 277     |   |                     |   |       |                         |  |                            | 204     |  |       |        |   |  |   | 481    
|Other income                        |  |                |        |   |                     |   |       |                         |  |                            |        |  |       |        |   |  |   |       
|Equity (income) loss                |  |                | (7,449  | ) |                     |   | (4,815 | )                       |  |                            |        |  |       | 12,264  |   |  |   |       
|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|Income (loss) before income tax     |  |                | 41,654  |   |                     |   | 4,814  |                         |  |                            | 10,769  |  |       | (12,264 | ) |  |   | 44,973 
|Provision for income taxes          |  |                | 11,988  |   |                     |   |       |                         |  |                            | 3,319   |  |       |        |   |  |   | 15,307 
|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        
|Net income (loss)                   |  | $              | 29,666  |   |                     | $ | 4,814  |                         |  | $                          | 7,450   |  | $     | (12,264 | ) |  | $ | 29,666 
|                                    |  |                |         |   |                     |   |        |                         |  |                            |         |  |       |         |   |  |   |        



INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Operations

For the three months ended June 30, 2009

(In thousands)



|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|----------------------------------- |  | -------------- | ------- | - | ------------------- | - | ------ | ----------------------- |  | - | -------------------------- | - |  | ----- | ------- | - |  | - | ------- | -
|                                    |  | Innophos, Inc. |         |   | GuarantorSubsidiary |   |        | Non-GuarantorSubsidiary |  |   | AdjustmentsandEliminations |   |  | Total |        
|Net Sales                           |  | $              | 133,359 |   |                     | $ |       |                         |  | $ | 70,079                     |   |  | $     | (36,672 | ) |  | $ | 166,766 |  
|Cost of goods sold                  |  |                | 91,189  |   |                     |   |       |                         |  |   | 62,854                     |   |  |       | (36,672 | ) |  |   | 117,371 |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Gross Profit                        |  |                | 42,170  |   |                     |   |       |                         |  |   | 7,225                      |   |  |       |        |   |  |   | 49,395  |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Operating expenses:                 |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Selling, general and administrative |  |                | 13,018  |   |                     |   |       |                         |  |   | 4,406                      |   |  |       |        |   |  |   | 17,424  |  
|Research & development expenses     |  |                | 533     |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 533     |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Total operating expenses            |  |                | 13,551  |   |                     |   |       |                         |  |   | 4,406                      |   |  |       |        |   |  |   | 17,957  |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Operating income                    |  |                | 28,619  |   |                     |   |       |                         |  |   | 2,819                      |   |  |       |        |   |  |   | 31,438  |  
|Interest expense, net               |  |                | 5,112   |   |                     |   |       |                         |  |   | 364                        |   |  |       |        |   |  |   | 5,476   |  
|Foreign exchange losses (gains)     |  |                | 52      |   |                     |   |       |                         |  |   | (742                       | ) |  |       |        |   |  |   | (690    | )
|Other income                        |  |                |        |   |                     |   |       |                         |  |   | 208                        |   |  |       |        |   |  |   | 208     |  
|Equity (income) loss                |  |                | (1,748  | ) |                     |   | 1,442  |                         |  |   |                           |   |  |       | 306     |   |  |   |        |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Income (loss) before income tax     |  |                | 25,203  |   |                     |   | (1,442 | )                       |  |   | 2,989                      |   |  |       | (306    | ) |  |   | 26,444  |  
|Provision for income taxes          |  |                | 8,705   |   |                     |   |       |                         |  |   | 1,241                      |   |  |       |        |   |  |   | 9,946   |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Net income (loss)                   |  | $              | 16,498  |   |                     | $ | (1,442 | )                       |  | $ | 1,748                      |   |  | $     | (306    | ) |  | $ | 16,498  |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  



20



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Operations

For the six months ended June 30, 2009

(In thousands)



|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|----------------------------------- |  | -------------- | ------- | - | ------------------- | - | ------ | ----------------------- |  | - | -------------------------- | - |  | ----- | ------- | - |  | - | ------- | -
|                                    |  | Innophos, Inc. |         |   | GuarantorSubsidiary |   |        | Non-GuarantorSubsidiary |  |   | AdjustmentsandEliminations |   |  | Total |        
|Net Sales                           |  | $              | 269,781 |   |                     | $ |       |                         |  | $ | 159,481                    |   |  | $     | (71,679 | ) |  | $ | 357,583 |  
|Cost of goods sold                  |  |                | 175,711 |   |                     |   |       |                         |  |   | 134,363                    |   |  |       | (71,679 | ) |  |   | 238,395 |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Gross Profit                        |  |                | 94,070  |   |                     |   |       |                         |  |   | 25,118                     |   |  |       |        |   |  |   | 119,188 |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Operating expenses:                 |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Selling, general and administrative |  |                | 23,516  |   |                     |   | 1      |                         |  |   | 7,883                      |   |  |       |        |   |  |   | 31,400  |  
|Research & development expenses     |  |                | 1,062   |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 1,062   |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Total operating expenses            |  |                | 24,578  |   |                     |   | 1      |                         |  |   | 7,883                      |   |  |       |        |   |  |   | 32,462  |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Operating (loss) income             |  |                | 69,492  |   |                     |   | (1     | )                       |  |   | 17,235                     |   |  |       |        |   |  |   | 86,726  |  
|Interest expense, net               |  |                | 10,610  |   |                     |   |       |                         |  |   | 931                        |   |  |       |        |   |  |   | 11,541  |  
|Foreign exchange losses (gains)     |  |                | 27      |   |                     |   |       |                         |  |   | (302                       | ) |  |       |        |   |  |   | (275    | )
|Other income                        |  |                |        |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   |        |  
|Equity (income) loss                |  |                | (10,820 | ) |                     |   | (3,260 | )                       |  |   |                           |   |  |       | 14,080  |   |  |   |        |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Income (loss) before income tax     |  |                | 69,675  |   |                     |   | 3,259  |                         |  |   | 16,606                     |   |  |       | (14,080 | ) |  |   | 75,460  |  
|Provision for income taxes          |  |                | 21,817  |   |                     |   |       |                         |  |   | 5,785                      |   |  |       |        |   |  |   | 27,602  |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Net income (loss)                   |  | $              | 47,858  |   |                     | $ | 3,259  |                         |  | $ | 10,821                     |   |  | $     | (14,080 | ) |  | $ | 47,858  |  
|                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  



21



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

For the six months ended June 30, 2010

(In thousands)



|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|---------------------------------------------------------------------------------------- |  | -------------- | ------- | - | ------------------- | - | ------ | ----------------------- |  | - | -------------------------- | - |  | ----- | ------- | - |  | - | ------- | -
|                                                                                         |  | Innophos, Inc. |         |   | GuarantorSubsidiary |   |        | Non-guarantorSubsidiary |  |   | AdjustmentsandEliminations |   |  | Total |        
|Cash Flows from operating activities                                                     |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Net income (loss)                                                                        |  | $              | 29,666  |   |                     | $ | 4,814  |                         |  | $ | 7,450                      |   |  | $     | (12,264 | ) |  | $ | 29,666  |  
|Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Depreciation and amortization                                                            |  |                | 13,455  |   |                     |   |       |                         |  |   | 11,459                     |   |  |       |        |   |  |   | 24,914  |  
|Amortization of deferred financing charges                                               |  |                | 708     |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 708     |  
|Deferred income tax (benefit) provision                                                  |  |                | (1,950  | ) |                     |   |       |                         |  |   | 789                        |   |  |       |        |   |  |   | (1,161  | )
|Deferred profit sharing                                                                  |  |                |        |   |                     |   |       |                         |  |   | (414                       | ) |  |       |        |   |  |   | (414    | )
|Share-based compensation                                                                 |  |                | 1,916   |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 1,916   |  
|Equity (income) loss in non-guarantor subsidiaries                                       |  |                | (7,449  | ) |                     |   | (4,815 | )                       |  |   |                           |   |  |       | 12,264  |   |  |   |        |  
|                                                                                         |  |                |         |   |                    
|Changes in assets and liabilities:                                                       |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Decrease in restricted cash                                                              |  |                |        |   |                     |   |       |                         |  |   | 1,749                      |   |  |       |        |   |  |   | 1,749   |  
|(Increase) decrease in accounts receivable                                               |  |                | (44,079 | ) |                     |   |       |                         |  |   | (39,263                    | ) |  |       | 60,880  |   |  |   | (22,462 | )
|Increase (decrease) in inventories                                                       |  |                | 7,694   |   |                     |   |       |                         |  |   | (9,252                     | ) |  |       |        |   |  |   | (1,558  | )
|Decrease (increase) in other current assets                                              |  |                | 4,019   |   |                     |   |       |                         |  |   | (10,026                    | ) |  |       | (1      | ) |  |   | (6,008  | )
|Increase (decrease) in accounts payable                                                  |  |                | 27,300  |   |                     |   |       |                         |  |   | 34,091                     |   |  |       | (60,880 | ) |  |   | 511     |  
|(Decrease) increase in other current liabilities                                         |  |                | (6,278  | ) |                     |   |       |                         |  |   | (10,335                    | ) |  |       | 1       |   |  |   | (16,612 | )
|Changes in other long-term assets and liabilities                                        |  |                | 9       |   |                     |   |       |                         |  |   | 374                        |   |  |       |        |   |  |   | 383     |  
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Net cash provided from (used for) operating activities                                   |  |                | 25,011  |   |                     |   | (1     | )                       |  |   | (13,378                    | ) |  |       |        |   |  |   | 11,632  |  
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Cash flows from investing activities:                                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Capital expenditures                                                                     |  |                | (11,655 | ) |                     |   |       |                         |  |   | (3,653                     | ) |  |       |        |   |  |   | (15,308 | )
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Net cash used for investing activities                                                   |  |                | (11,655 | ) |                     |   |       |                         |  |   | (3,653                     | ) |  |       |        |   |  |   | (15,308 | )
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Cash flows from financing activities:                                                    |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Repayment from subsidiaries                                                              |  |                |        |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   |        |  
|Net change in borrowing with Innophos, Inc.                                              |  |                |        |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   |        |  
|Return of capital to parent                                                              |  |                | (62,054 | ) |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | (62,054 | )
|Excess tax benefits from exercise of stock options                                       |  |                | 175     |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 175     |  
|Deferred financing costs                                                                 |  |                |        |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   |        |  
|Principal payment of term loans                                                          |  |                |        |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   |        |  
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Net cash used for financing activities                                                   |  |                | (61,879 | ) |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | (61,879 | )
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Net change in cash                                                                       |  |                | (48,523 | ) |                     |   | (1     | )                       |  |   | (17,031                    | ) |  |       |        |   |  |   | (65,555 | )
|Cash and cash equivalents at beginning of period                                         |  |                | 72,079  |   |                     |   | 2      |                         |  |   | 60,141                     |   |  |       |        |   |  |   | 132,222 |  
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  
|Cash and cash equivalents at end of period                                               |  | $              | 23,556  |   |                     | $ | 1      |                         |  | $ | 43,110                     |   |  | $     |        |   |  | $ | 66,667  |  
|                                                                                         |  |                |         |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |         |  



22



---

##### Table of Contents

INNOPHOS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

(Dollars in thousands, except where noted)



INNOPHOS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

For the six months ended June 30, 2009

(In thousands)



|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|---------------------------------------------------------------------------------------- |  | -------------- | -------- | - | ------------------- | - | ------ | ----------------------- |  | - | -------------------------- | - |  | ----- | ------- | - |  | - | -------- | -
|                                                                                         |  | Innophos, Inc. |          |   | GuarantorSubsidiary |   |        | Non-guarantorSubsidiary |  |   | AdjustmentsandEliminations |   |  | Total |        
|Cash Flows from operating activities                                                     |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Net income (loss)                                                                        |  | $              | 47,858   |   |                     | $ | 3,259  |                         |  | $ | 10,821                     |   |  | $     | (14,080 | ) |  | $ | 47,858   |  
|Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Depreciation and amortization                                                            |  |                | 12,772   |   |                     |   |       |                         |  |   | 11,077                     |   |  |       |        |   |  |   | 23,849   |  
|Amortization of deferred financing charges                                               |  |                | 1,934    |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 1,934    |  
|Deferred income tax benefit                                                              |  |                | (977     | ) |                     |   |       |                         |  |   | (787                       | ) |  |       |        |   |  |   | (1,764   | )
|Deferred profit sharing                                                                  |  |                |         |   |                     |   |       |                         |  |   | (230                       | ) |  |       |        |   |  |   | (230     | )
|Share-based compensation                                                                 |  |                | 1,219    |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 1,219    |  
|Equity (income) loss in non-guarantor subsidiaries                                       |  |                | (10,820  | ) |                     |   | (3,260 | )                       |  |   |                           |   |  |       | 14,080  |   |  |   |         |  
|                                                                                         |  |                |          |   |                    
|Changes in assets and liabilities:                                                       |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Increase in restricted cash                                                              |  |                |         |   |                     |   |       |                         |  |   | (1,748                     | ) |  |       |        |   |  |   | (1,748   | )
|(Increase) decrease in accounts receivable                                               |  |                | (36,994  | ) |                     |   |       |                         |  |   | (31,866                    | ) |  |       | 81,418  |   |  |   | 12,558   |  
|Decrease in inventories                                                                  |  |                | 14,608   |   |                     |   |       |                         |  |   | 16,635                     |   |  |       |        |   |  |   | 31,243   |  
|Decrease (increase) in other current assets                                              |  |                | 2,883    |   |                     |   |       |                         |  |   | (1,341                     | ) |  |       | (355    | ) |  |   | 1,187    |  
|Increase (decrease) in accounts payable                                                  |  |                | 41,780   |   |                     |   |       |                         |  |   | 37,907                     |   |  |       | (81,418 | ) |  |   | (1,731   | )
|(Decrease) increase in other current liabilities                                         |  |                | (472     | ) |                     |   |       |                         |  |   | 4,901                      |   |  |       | 355     |   |  |   | 4,784    |  
|Changes in other long-term assets and liabilities                                        |  |                | 384      |   |                     |   |       |                         |  |   | 254                        |   |  |       |        |   |  |   | 638      |  
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Net cash provided from (used for) operating activities                                   |  |                | 74,175   |   |                     |   | (1     | )                       |  |   | 45,623                     |   |  |       |        |   |  |   | 119,797  |  
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Cash flows from investing activities:                                                    |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Capital expenditures                                                                     |  |                | (5,269   | ) |                     |   |       |                         |  |   | (2,371                     | ) |  |       |        |   |  |   | (7,640   | )
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Net cash used for investing activities                                                   |  |                | (5,269   | ) |                     |   |       |                         |  |   | (2,371                     | ) |  |       |        |   |  |   | (7,640   | )
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Cash flows from financing activities:                                                    |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Repayment from subsidiaries                                                              |  |                | 50,000   |   |                     |   |       |                         |  |   |                           |   |  |       | (50,000 | ) |  |   |         |  
|Net change in borrowing with Innophos, Inc.                                              |  |                |         |   |                     |   |       |                         |  |   | (50,000                    | ) |  |       | 50,000  |   |  |   |         |  
|Return of capital to parent                                                              |  |                | (26,161  | ) |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | (26,161  | )
|Excess tax benefits from exercise of stock options                                       |  |                | 2        |   |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | 2        |  
|Deferred financing costs                                                                 |  |                | (1,050   | ) |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | (1,050   | )
|Principal payment of term loans                                                          |  |                | (126,500 | ) |                     |   |       |                         |  |   |                           |   |  |       |        |   |  |   | (126,500 | )
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Net cash used for financing activities                                                   |  |                | (103,709 | ) |                     |   |       |                         |  |   | (50,000                    | ) |  |       |        |   |  |   | (153,709 | )
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Net change in cash                                                                       |  |                | (34,803  | ) |                     |   | (1     | )                       |  |   | (6,748                     | ) |  |       |        |   |  |   | (41,552  | )
|Cash and cash equivalents at beginning of period                                         |  |                | 61,295   |   |                     |   | 5      |                         |  |   | 63,323                     |   |  |       |        |   |  |   | 124,623  |  
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  
|Cash and cash equivalents at end of period                                               |  | $              | 26,492   |   |                     | $ | 4      |                         |  | $ | 56,575                     |   |  | $     |        |   |  | $ | 83,071   |  
|                                                                                         |  |                |          |   |                     |   |        |                         |  |   |                            |   |  |       |         |   |  |   |          |  



23



---

##### Table of Contents

|ITEM 2. | MANAGEMENTS DISCUSSION & ANALYSIS OF FINANCIAL CONDITION & RESULTS OF OPERATIONS
|------- | ---------------------------------------------------------------------------------

This discussion contains forward-looking statements about our markets, the demand for our products and services and our future results.
We based these statements on assumptions that we consider reasonable. Actual results may differ materially from those suggested by our forward-looking statements for various reasons including those discussed in the Risk Factors as
contained in our 2009 Annual Report on Form 10-K and Forward-Looking Statements sections of that report.

Innophos is a leading North American producer of specialty phosphates. Most specialty phosphates are highly customized,
application-specific compounds that are engineered to meet customer performance requirements. Specialty phosphates are often critical to the taste, texture and performance of foods, beverages, pharmaceuticals, oral care products and other
applications. For example, specialty phosphates act as flavor enhancers in beverages, electrolytes in sports drinks, texture additives in cheeses, leavening agents in baked goods, calcium and phosphorus sources for nutritional supplements,
pharmaceutical excipients and cleaning agents in toothpaste.

Recent Trends and Outlook

Second quarter 2010 results demonstrated strong ongoing year over year volume growth for specialty phosphates, with recovery evident in
the industrial markets most affected by recessionary conditions in 2009 and in the ongoing strength in sales to consumer oriented end markets. Volume growth is expected to continue for the third quarter, leading to an expected sequential net sales
growth in excess of 5% for specialty phosphates and over 10% sales growth on a year over year basis.

Specialty phosphates
selling prices improved moderately in comparison to first quarter following increases implemented in March and April, and going forward management expects to maintain its operating margin level through the third quarter.

GTSP volume for the second half 2010 is expected to be similar to the first half, although the timing of large orders generally leads to
variability in individual quarterly results. Market pricing is currently stable.

As expected, second quarter gross profit
benefited from the impact of adjustments to contracted purchase prices effective January 2010, reflecting market conditions at the beginning of the year. Since these contract prices reset, commodity fertilizer and related raw material prices such as
sulfur have increased. Although Innophos continues to expect some moderation in market prices before contract prices reset for 2011, managements expectation remains that an approximate $5 million per quarter cost increase from higher contract
raw material prices will phase in beginning with the fourth quarter 2010 and take full effect in the second quarter 2011.

Continued progress has been made on executing our rock diversification strategy. The Company signed its first new rock contract on May 3rd, and has taken shipload quantities from three different potential sources and continues to advance
negotiations for both short and long term supply.

Capital expenditure expectations for 2010 remain approximately $35 million,
with expenditure for the balance of the year to continue debottlenecking of US / Canada specialty salts facilities and to enhance Mexicos capability to process multiple grades of rock consistent with the Companys supply chain
diversification strategy. In addition, limited investment continues to evaluate Innophos Mexican phosphate rock concessions. Following a review of the status of the Companys ERP project, management anticipates an implementation in early
2011 with expenditure continuing at a reduced rate versus the first half of 2010.

Net debt (defined as total debt less cash
and cash equivalents) improved moderately to $123 million at the end of the second quarter despite a build of working capital to support higher operating rates in Mexico. Strong cash flow generation is expected for the balance of the year. This will
allow management to continue with its previously stated objectives of maintaining the dividend, pursuing several bolt-on acquisition projects and actively seeking opportunities to optimize the cost and profile of the Companys debt
structure.



24



---

##### Table of Contents

Historical Performance

Results of Operations

The following table sets forth a summary of the Companys operations and their percentages of total revenue for the periods
indicated.



|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|----------------------------------- |  | ------------------ | ----- | ------------------ | ----- | ------ | - | ----- | - |  | ----- | -
|                                    |  | Three months ended |       | Three months ended |      
|                                    |  | June 30,2010       |       | June 30,2009       |      
|                                    |  | Amount             |       | %                  |       | Amount |   |       | % | 
|Net sales                           |  | $                  | 184.0 |                    | 100.0 |        | $ | 166.8 |   |  | 100.0 |  
|Cost of goods sold                  |  |                    | 136.9 |                    | 74.4  |        |   | 117.4 |   |  | 70.4  |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|Gross profit                        |  |                    | 47.1  |                    | 25.6  |        |   | 49.4  |   |  | 29.6  |  
|Operating expenses:                 |  |                    |       |                    |       |        |   |       |   |  |       |  
|Selling, general and administrative |  |                    | 13.8  |                    | 7.5   |        |   | 17.5  |   |  | 10.5  |  
|Research & development expenses     |  |                    | 0.6   |                    | 0.3   |        |   | 0.5   |   |  | 0.3   |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|Operating income                    |  |                    | 32.7  |                    | 17.8  |        |   | 31.4  |   |  | 18.8  |  
|Interest expense, net               |  |                    | 4.4   |                    | 2.4   |        |   | 5.5   |   |  | 3.3   |  
|Foreign exchange loss (gain), net   |  |                    | 0.7   |                    | 0.4   |        |   | (0.7  | ) |  | (0.4  | )
|Other income                        |  |                    |      |                    |      |        |   | 0.2   |   |  | 0.1   |  
|Provision for income taxes          |  |                    | 9.2   |                    | 5.0   |        |   | 9.9   |   |  | 5.9   |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|Net income                          |  | $                  | 18.4  |                    | 10.0  |        | $ | 16.5  |   |  | 9.9   |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|                                    |  |                   
|                                    |  | Six months ended   |       | Six months ended   |      
|                                    |  | June 30,2010       |       | June 30,2009       |      
|                                    |  | Amount             |       | %                  |       | Amount |   |       | % | 
|Net sales                           |  | $                  | 353.0 |                    | 100.0 |        | $ | 357.6 |   |  | 100.0 |  
|Cost of goods sold                  |  |                    | 269.2 |                    | 76.3  |        |   | 238.4 |   |  | 66.7  |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|Gross profit                        |  |                    | 83.8  |                    | 23.7  |        |   | 119.2 |   |  | 33.3  |  
|Operating expenses:                 |  |                    |       |                    |       |        |   |       |   |  |       |  
|Selling, general and administrative |  |                    | 28.3  |                    | 8.0   |        |   | 31.4  |   |  | 8.8   |  
|Research & development expenses     |  |                    | 1.2   |                    | 0.3   |        |   | 1.1   |   |  | 0.3   |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|Operating income                    |  |                    | 54.3  |                    | 15.4  |        |   | 86.7  |   |  | 24.2  |  
|Interest expense, net               |  |                    | 8.8   |                    | 2.5   |        |   | 11.5  |   |  | 3.2   |  
|Foreign exchange loss (gain), net   |  |                    | 0.5   |                    | 0.1   |        |   | (0.3  | ) |  | (0.1  | )
|Provision for income taxes          |  |                    | 15.3  |                    | 4.3   |        |   | 27.6  |   |  | 7.7   |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  
|Net income                          |  | $                  | 29.7  |                    | 8.4   |        | $ | 47.9  |   |  | 13.4  |  
|                                    |  |                    |       |                    |       |        |   |       |   |  |       |  

Three months ended June 30, 2010 compared to the three months ended June 30, 2009

Net Sales

Net sales represent the selling price of the products, net of any customer-related rebates, plus freight and any other items invoiced to
customers. Net sales for the three months ended June 30, 2010 were $184.0 million, an increase of $17.2 million, or 10.3%, as compared to $166.8 million for the same period in 2009. Volume effects upon revenue were positive 27.5% or $45.9
million which occurred across all product lines and segments. Selling price decreases had a negative effect on revenue of 17.2% or $28.7 million which occurred in both US/Canada and Mexico Specialty Phosphates. GTSP prices improved in line with
market prices in comparison to last year. GTSP sales volumes increased significantly as a result both of increased purified acid production leading to higher co-product volumes and favorable order pattern in the quarter.



25



---

##### Table of Contents

The Company calculates pure selling price dollar variances as the selling price for the
current period minus the selling price for the prior period, and then multiplies the resulting selling price difference by the prior period volume. The selling price dollar variance is then divided by the prior period sales dollars to calculate the
percentage change. Volume/mix variance is calculated as the total sales variance minus the selling price variance. The following table illustrates for the three months ended June 30, 2010 the percentage changes in net sales by reportable
segment compared with the same period in 2009, including the effects of price and volume/mix upon revenue:



|                                 |  |       |    |  |            |   |  |       |   
|-------------------------------- |  | ----- | -- |  | ---------- | - |  | ----- | --
|                                 |  | Price |    |  | Volume/Mix |   |  | Total |   
|Specialty Phosphates US & Canada |  | (19.0 | %) |  | 15.8       | % |  | (3.2  | %)
|Specialty Phosphates Mexico      |  | (23.3 | %) |  | 38.9       | % |  | 15.6  | % 
|GTSP & Other                     |  | 59.1  | %  |  | 222.8      | % |  | 281.9 | % 

The following
table illustrates for the three months ended June 30, 2010 the percentage changes for net sales by major product lines compared with the same period in 2009, including the effect of price and volume/mix effects upon revenue:



|                                    |  |       |    |  |            |   |  |       |   
|----------------------------------- |  | ----- | -- |  | ---------- | - |  | ----- | --
|                                    |  | Price |    |  | Volume/Mix |   |  | Total |   
|Specialty Salts and Specialty Acids |  | (16.6 | %) |  | 17.0       | % |  | 0.4   | % 
|Food & Technical Grade Acid         |  | (26.6 | %) |  | 34.6       | % |  | 8.0   | % 
|STPP & Detergent Grade Acid         |  | (28.3 | %) |  | 23.4       | % |  | (4.9  | %)
|GTSP & Other                        |  | 59.1  | %  |  | 222.8      | % |  | 281.9 | % 

Gross
Profit

Gross profit represents net sales less cost of goods sold. Gross profit for the three months ended June 30,
2010 was $47.1 million, a decrease of $2.3 million, or 4.7%, as compared to $49.4 million for the same period in 2009. Gross margin decreased to 25.6% for the three months ended June 30, 2010 versus 29.6% for the same period in 2009. The change
in gross profit was primarily due to lower selling prices which had an unfavorable effect of $28.7 million, $0.8 million unfavorable exchange rate impact mostly from our Mexican peso based costs, and $1.1 million expense for the planned maintenance
outage at our Geismar La. manufacturing facility. This was mostly offset by favorable sales volume, lower raw material cost, and lower manufacturing cost which resulted in a net favorable effect of $22.8 million. Included in the 2009 second quarter
results were $1.2 million Mexican workforce reduction costs, $1.8 million inventory write-downs of granular triple super-phosphate, and a charge of $2.5 million for anticipated unfulfilled contractual natural gas purchase commitments.

Operating Expenses and Research and Development

Operating expenses consist primarily of selling, general and administrative, and R&D expenses. For the three months ended
June 30, 2010, these costs were $14.4 million, a decrease of $3.6 million, or 20.0%, as compared to $18.0 million for the same period in 2009. The decrease is due to $1.9 million lower enterprise resource planning system and business redesign
project (ERP) expenses as a result of capitalizing the implementation phase costs, $0.9 million lower legal expenses related to our OCP arbitration, and $0.4 million reduction in all other costs. Included in 2009 second quarter results was a charge
of $0.4 million Mexican workforce reduction costs.

Operating Income

Operating income for the three months ended June 30, 2010 was $32.7 million, an increase of $1.3 million, or 4.1%, as compared to
$31.4 million for the same period in 2009. Operating income as a percentage of net sales for the Company decreased to 17.8% versus 18.8% for the same period in 2009.

Interest Expense, net

Net interest expense, including deferred financing amortization expense, for the three months ended June 30, 2010 was $4.4 million, a
decrease of $1.1 million, compared to $5.5 million for the same period in 2009. This decrease is primarily due to the pay off of the remaining balance of the Term Loan in the second quarter of 2009.

Foreign Exchange

Foreign exchange loss for the three months ended June 30, 2010 was $0.7 million compared to a gain of $0.7 million for the same
period in 2009 as a result of the remeasurement of the non-U.S. dollar denominated monetary assets and liabilities. The U.S. dollar is the functional currency of our Mexican and Canadian operations. Consequently, foreign exchange gain or loss is
recorded on remeasurement of non-U.S. dollar denominated monetary assets and liabilities. Such gains and losses fluctuate from period to period as the foreign currencies strengthen or weaken against the U.S. dollar and the amount of non-U.S. dollar
denominated assets and liabilities increases or decreases.



26



---

##### Table of Contents

Provision for Income Taxes

The effective income tax rate on income before taxes was 33% for the three months ended June 30, 2010 compared to 38% for the same
period in 2009. The change in the effective tax rate is a result of increased earnings before tax in lower tax rate jurisdictions combined with a change in tax rates for our operations in multiple tax jurisdictions.

Net Income

Net income for the three months ended June 30, 2010 was $18.4 million, the same as net income of $16.5 million for the same period in
2009, due to the factors described above.

Six months ended June 30, 2010 compared to the six months ended June 30, 2009

Net Sales

Net sales represent the selling price of the products, net of any customer-related rebates, plus freight and any other items invoiced to
customers. Net sales for the six months ended June 30, 2010 were $353.0 million, a decrease of $4.6 million, or 1.3%, as compared to $357.6 million for the same period in 2009. Selling price decreases had a negative effect on revenue of 20.6%
or $73.5 million which occurred in US/Canada and Mexico Specialty Phosphates. GTSP prices increased for the comparable period in-line with market prices. Volume effects upon revenue were positive 19.3% or $68.9 million which occurred across all
product lines and segments.

The following table illustrates for the six months ended June 30, 2010 the percentage
changes in net sales by reportable segment compared with the same period in 2009, including the effect of price and volume/mix effects upon revenue:



|                                 |  |       |    |  |            |   |  |       |   
|-------------------------------- |  | ----- | -- |  | ---------- | - |  | ----- | --
|                                 |  | Price |    |  | Volume/Mix |   |  | Total |   
|Specialty Phosphates US & Canada |  | (23.3 | %) |  | 18.3       | % |  | (5.0  | %)
|Specialty Phosphates Mexico      |  | (27.1 | %) |  | 24.0       | % |  | (3.1  | %)
|GTSP & Other                     |  | 30.7  | %  |  | 15.6       | % |  | 46.3  | % 

The following
table illustrates for the six months ended June 30, 2010 the percentage changes for net sales by major product lines compared with the same period in 2009, including the effect of price and volume/mix effects upon revenue:



|                                    |  |       |    |  |            |   |  |       |   
|----------------------------------- |  | ----- | -- |  | ---------- | - |  | ----- | --
|                                    |  | Price |    |  | Volume/Mix |   |  | Total |   
|Specialty Salts and Specialty Acids |  | (19.7 | %) |  | 19.0       | % |  | (0.7  | %)
|Food & Technical Grade Acid         |  | (35.9 | %) |  | 27.5       | % |  | (8.4  | %)
|STPP & Detergent Grade Acid         |  | (29.8 | %) |  | 13.2       | % |  | (16.6 | %)
|GTSP & Other                        |  | 30.7  | %  |  | 15.6       | % |  | 46.3  | % 

Gross
Profit

Gross profit represents net sales less cost of goods sold. Gross profit for the six months ended June 30, 2010
was $83.8 million, a decrease of $35.4 million, or 29.7%, as compared to $119.2 million for the same period in 2009. Gross margin decreased to 23.7% for the six months ended June 30, 2010 versus 33.3% for the same period in 2009. The change in
gross profit was primarily due to lower selling prices which had an unfavorable effect of $73.5 million, $1.4 million unfavorable exchange rate impact mostly from our Mexican peso based costs, and $1.1 million expense for the planned maintenance
outage at our Geismar La. manufacturing facility. This was partially offset by favorable sales volume combined with lower raw material and manufacturing costs which resulted in a net favorable effect of $34.7 million. Included in the 2009 results
were $1.6 million Mexican workforce reduction costs, $1.8 million inventory write-downs of granular triple super-phosphate, and a charge of $2.5 million for anticipated unfulfilled contractual natural gas purchase commitments.

Operating Expenses and Research and Development

Operating expenses consist primarily of selling, general and administrative, and R&D expenses. For the six months ended June 30,
2010, these costs were $29.5 million, a decrease of $3.0 million, or 9.2%, as compared to $32.5 million for the same period in 2009. The decrease is due to $1.9 million lower ERP expenses as a result of capitalizing the implementation phase costs,
$1.5 million lower legal and other professional services, and $0.9 million lower legal expenses related to our OCP arbitration. This was partially offset by $1.6 million increased short term incentive accruals. Included in 2009 second quarter
results was a charge of $0.4 million Mexican workforce reduction costs.



27



---

##### Table of Contents

Operating Income

Operating income for the six months ended June 30, 2010 was $54.3 million, a decrease of $32.4 million, or 37.4%, as compared to
$86.7 million for the same period in 2009. Operating income as a percentage of net sales for the Company decreased to 15.4% versus 24.2% for the same period in 2009.

Interest Expense, net

Net interest expense, including deferred financing amortization expense, for the six months ended June 30, 2010 was $8.8 million, a
decrease of $2.7 million, compared to $11.5 million for the same period in 2009. This decrease is primarily due to the pay off of the remaining balance of the Term Loan in the second quarter of 2009.

Foreign Exchange

Foreign exchange loss for the six months ended June 30, 2010 was $0.5 million compared to a gain of $0.3 million for the same period
in 2009 as a result of the remeasurement of the non-U.S. dollar denominated monetary assets and liabilities. The U.S. dollar is the functional currency of our Mexican and Canadian operations. Consequently, foreign exchange gain or loss is recorded
on remeasurement of non-U.S. dollar denominated monetary assets and liabilities. Such gains and losses fluctuate from period to period as the foreign currencies strengthen or weaken against the U.S. dollar and the amount of non-U.S. dollar
denominated assets and liabilities increases or decreases.

Provision for Income Taxes

The effective income tax rate on income before taxes was 34% for the six months ended June 30, 2010 compared to 37% for the same
period in 2009. The change in the effective tax rate is a result of increased earnings before tax in lower tax rate jurisdictions combined with a change in tax rates for our operations in multiple tax jurisdictions.

Net Income

Net income for the six months ended June 30, 2010 was $29.7 million, a decrease of $18.2 million, compared to net income of $47.9
million for the same period in 2009, due to the factors described above.



28



---

##### Table of Contents

Segment Reporting

Beginning with the second quarter, the Company reported its core specialty phosphates business separately from GTSP and other
non-specialty phosphate products. The previous reported segments of the United States, Mexico and Canada changed to Specialty Phosphates US & Canada, Specialty Phosphates Mexico and GTSP & Other. Specialty phosphates consists of
the products lines Specialty Salts and Specialty Acids, Food & Technical Grade Acid, and STPP & Detergent Grade Acid. GTSP & Other includes fertilizer co-product GTSP and other non-specialty phosphate products. The primary
performance indicators for the chief operating decision maker are sales and operating income. The following table sets forth the historical results of these indicators by segment:



|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|--------------------------------------- |  | ------------------------------- | ------- | - | ------------------------------- | - | ------- | ------------------ |  | ----- | --
|                                        |  | Three months endedJune 
30,2010 |         |   | Three months endedJune 
30,2009 |   |         | Net Sales % Change | 
|Segment Net Sales                       |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Specialty Phosphates US & Canada        |  | $                               | 123,086 |   |                                 | $ | 127,098 |                    |  | (3.2  | %)
|Specialty Phosphates Mexico             |  |                                 | 39,298  |   |                                 |   | 34,000  |                    |  | 15.6  | % 
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total Specialty Phosphates              |  | $                               | 162,384 |   |                                 | $ | 161,098 |                    |  | 0.8   | % 
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|GTSP & Other                            |  |                                 | 21,648  |   |                                 |   | 5,668   |                    |  | 281.9 | % 
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total                                   |  | $                               | 184,032 |   |                                 | $ | 166,766 |                    |  | 10.4  | % 
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Segment Operating Income                |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Specialty Phosphates US & Canada        |  | $                               | 26,758  |   |                                 | $ | 33,024  |                    |  |       |   
|Specialty Phosphates Mexico             |  |                                 | 4,011   |   |                                 |   | 5,778   |                    |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total Specialty Phosphates              |  | $                               | 30,769  |   |                                 | $ | 38,802  |                    |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|GTSP & Other                            |  |                                 | 1,908   |   |                                 |   | (7,364  | )                  |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total                                   |  | $                               | 32,677  |   |                                 | $ | 31,438  |                    |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Segment Operating Income % of net sales |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Specialty Phosphates US & Canada        |  |                                 | 21.7    | % |                                 |   | 26.0    | %                  |  |       |   
|Specialty Phosphates Mexico             |  |                                 | 10.2    | % |                                 |   | 17.0    | %                  |  |       |   
|Total Specialty Phosphates              |  |                                 | 18.9    | % |                                 |   | 24.1    | %                  |  |       |   
|GTSP & Other                            |  |                                 | 8.8     | % |                                 |   | (129.9  | %)                 |  |       |   
|                                        |  |                                 |        
|                                        |  | Six months endedJune
30,2010    |         |   | Six months endedJune
30,2009    |   |         | Net Sales % Change | 
|Segment Net Sales                       |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Specialty Phosphates US & Canada        |  | $                               | 246,444 |   |                                 | $ | 259,488 |                    |  | (5.0  | %)
|Specialty Phosphates Mexico             |  |                                 | 72,497  |   |                                 |   | 74,781  |                    |  | (3.1  | %)
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total Specialty Phosphates              |  | $                               | 318,941 |   |                                 |   | 334,269 |                    |  | (4.6  | %)
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|GTSP & Other                            |  |                                 | 34,098  |   |                                 |   | 23,314  |                    |  | 46.3  | % 
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total                                   |  | $                               | 353,039 |   |                                 | $ | 357,583 |                    |  | (1.3  | %)
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Segment Operating Income                |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Specialty Phosphates US & Canada        |  | $                               | 46,819  |   |                                 | $ | 80,795  |                    |  |       |   
|Specialty Phosphates Mexico             |  |                                 | 5,434   |   |                                 |   | 14,938  |                    |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total Specialty Phosphates              |  | $                               | 52,253  |   |                                 |   | 95,733  |                    |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|GTSP & Other                            |  |                                 | 2,049   |   |                                 |   | (9,007  | )                  |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Total                                   |  | $                               | 54,302  |   |                                 | $ | 86,726  |                    |  |       |   
|                                        |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Segment Operating Income % of net sales |  |                                 |         |   |                                 |   |         |                    |  |       |   
|Specialty Phosphates US & Canada        |  |                                 | 19.0    | % |                                 |   | 31.1    | %                  |  |       |   
|Specialty Phosphates Mexico             |  |                                 | 7.5     | % |                                 |   | 20.0    | %                  |  |       |   
|Total Specialty Phosphates              |  |                                 | 16.4    | % |                                 |   | 28.6    | %                  |  |       |   
|GTSP & Other                            |  |                                 | 6.0     | % |                                 |   | (38.6   | %)                 |  |       |   



29



---

##### Table of Contents

Three months ended June 30, 2010 compared to the three months ended June 30, 2009

Segment Net Sales:

Specialty Phosphates US & Canada net sales decreased 3.2% for the three months ended June 30, 2010 when compared with the
same period in 2009. Selling prices decreased 19.0% with decreases across all product lines. Volume impact upon revenue increased of 15.8% with increases across all product lines but most notably in Food & Technical Grade Acid.

Specialty Phosphates Mexico net sales increased 15.6% for the three months ended June 30, 2010 when compared with the same period in
2009. Selling prices decreased 23.3% with decreases across all product lines. Volume impact upon revenue was an increase of 38.9% with increases across all product lines.

GTSP & Other net sales increased 281.9% for the three months ended June 30, 2010 when compared with the same period in 2009 on higher
selling prices and substantially higher volumes. GTSP sales volumes increased significantly as a result both of increased purified acid production leading to higher co-product volumes and favorable order pattern in the quarter. GTSP prices improved
in line with market prices in comparison to last year.

Segment Operating Income % of Net Sales:

The 4.3% decrease in Specialty Phosphates US & Canada for the three months ended June 30, 2010 compared with the same period
in 2009 is mainly due to decreased selling prices, partially offset by increased volume/mix effects on revenue, lower raw material costs, and lower operating expenses.

The 6.8% decrease in Specialty Phosphates Mexico for the three months ended June 30, 2010 compared with the same period in 2009 is
mainly due to decreased selling prices partially offset by increased volume effects on revenue, decreased manufacturing expenses, and lower operating expenses. Included in the 2009 second quarter results were $1.2 million Mexican workforce reduction
costs.

The 138.7% increase in GTSP & Other for the three months ended June 30, 2010 compared with the same
period in 2009 is primarily due to higher selling prices and significantly higher volumes. Included in the 2009 second quarter results were $1.8 million inventory write-downs of granular triple super-phosphate, and a charge of $2.5 million for
anticipated unfulfilled contractual natural gas purchase commitments.

Six months ended June 30, 2010 compared to the six months
ended June 30, 2009

Segment Net Sales:

Specialty Phosphates US & Canada net sales decreased 5.0% for the six months ended June 30, 2010 when compared with the same
period in 2009. Selling prices decreased 23.3% with decreases across all product lines. Volume effects upon revenue was an increase of 18.3% with increases across all product lines but most notably in Specialty Salts and Specialty Acids.

Specialty Phosphates Mexico net sales decreased 3.1% for the six months ended June 30, 2010 when compared with the same period in
2009. Selling prices decreased 27.1% with decreases across all product lines. Volume effects upon revenue was an increase of 24.0% with increases across all product lines.

GTSP & Other net sales increased 46.3% for the six months ended June 30, 2010 when compared with the same period in 2009
primarily on higher selling prices. GTSP prices improved in-line with market prices in comparison to last year.

Segment Operating
Income % of Net Sales:

The 12.1% decrease in Specialty Phosphates US & Canada for the six months ended
June 30, 2010 compared with the same period in 2009 is mainly due to decreased selling prices and increased manufacturing expenses (higher volumes and Geismar turnaround), partially offset by increased volumes, lower raw material costs and
lower operating expenses.

The 12.5% decrease in Specialty Phosphates Mexico for the six months ended June 30, 2010
compared with the same period in 2009 is mainly due to decreased selling prices partially offset by increased volumes and decreased manufacturing expenses. Included in the 2009 results were $1.6 million Mexican workforce reduction costs.

The 44.6% increase in GTSP & Other for the six months ended June 30, 2010 compared with the same period in 2009 is
primarily due to higher selling prices. Included in the 2009 results were $1.8 million inventory write-downs of granular triple super-phosphate, and a charge of $2.5 million for anticipated unfulfilled contractual natural gas purchase commitments.

Liquidity and Capital Resources

The following table sets forth a summary of the Companys cash flows for the periods indicated.



30



---

##### Table of Contents

|                     |  |                               |       |   |                               |   |        |  
|-------------------- |  | ----------------------------- | ----- | - | ----------------------------- | - | ------ | -
|                     |  | Six months endedJune 
30,2010 |       |   | Six months endedJune 
30,2009 |  
|Operating Activities |  | $                             | 11.6  |   |                               | $ | 119.8  |  
|Investing Activities |  |                               | (15.3 | ) |                               |   | (7.6   | )
|Financing Activities |  |                               | (61.9 | ) |                               |   | (153.7 | )

Six months ended June 30, 2010
compared to six months ended June 30, 2009

Net cash from operating activities was a source of $11.6 million for
the six months ended June 30, 2010 as compared to source of $119.8 million for the same period in 2009, a decrease in cash of $108.2 million. The decrease in operating activities cash resulted primarily from unfavorable changes of $90.7 million
in working capital and $18.2 million in net income as described earlier.

The change in working capital is a use of cash of
$44.4 million in 2010 compared to a source of cash of $46.3 million in 2009, a decrease in cash of $90.7 million. The decrease in cash is mainly due to increases in accounts receivable and inventory levels due to higher operating rates in Mexico,
and decreased other current liabilities.

Net cash used for investing activities was $15.3 million for the six months ended
June 30, 2010, compared to $7.6 million for the same period in 2009, an increase in the use of cash of $7.7 million. This increase was mainly due to the Companys ERP project.

In the second quarter of 2009 the Company launched an ERP project to upgrade its systems technology and to improve its position as a
reliable specialty phosphate supplier. To date the Company has spent approximately $20.0 million on this project, of which approximately $13.1 million was capitalized as of June 30, 2010. Following a review of the status of the Companys
ERP project, management anticipates an implementation in early 2011 with expenditure continuing at a reduced rate versus the first half of 2010.

The Company is investing to grow its food, beverage and pharmaceutical phosphate business, especially geographically, and also to
diversify its raw material supply long term. Projects are underway in the U.S. to debottleneck and increase production capabilities of various specialty salts. Additionally, in conjunction with the investment in the Coatzacoalcos facility to more
than double its existing food grade purified phosphoric acid capacity which was completed in the first quarter 2010, the site personnel have conducted successful production tests of several additional food grade salts to enable a shift in focus from
detergency to the multiple food market segments served by salts and acid.

Innophos currently estimates that full exploration
costs to a proven reserves standard for the Baja California Sur deposits could require expenditures of $10 to $15 million over a three year period, inclusive of expenditures to date. This estimate includes mineral rights payments, taxes,
mineral resource measurement, beneficiation process design and completion of feasibility studies. Full expenditures would only occur if interim milestone goals were successfully attained. It is estimated that 2010 expenditures will be approximately
$0.7 to $1.5 million. Innophos intends to seek one or more partners for these efforts, but anticipates no difficulties in completing the exploration phase without a partnership.

Management projects total 2010 capital expenditures to approximate $30 to $35 million with the likely outcome at the high end of the
range.

Net cash from financing activities for the six months ended June 30, 2010 was a use of $61.9 million compared to
$153.7 million for the same period in 2009, an increase in cash of $91.8 million. This is mainly due to $126.5 million of Term Loan principal payments in 2009 offset by a $35.9 million return of capital to our parent.

On April 13, 2009 Holdings purchased $10.0 million of the 9.5% Senior Unsecured Notes due April 2012 for $6.5 million. The $3.5
million retirement gain is reflected as interest income in Holdings Consolidated Statement of Operations in the second quarter of 2009. The Company also recorded accelerated deferred financing costs of approximately $0.2 million in the second
quarter of 2009.

Holdings redeemed for cash all remaining $56.0 million of the Senior Unsecured Notes on April 15, 2010,
the Redemption Date. The redemption price for the Notes was 100% of the principal amount plus accrued interest of $2.7 million to the Redemption Date. Accelerated deferred financing charges of $0.6 million were recorded in the second quarter of
2010.

Innophos and its subsidiaries and affiliates may from time to time seek to acquire or otherwise retire outstanding debt
(including publicly issued debt) through open market purchases, privately negotiated transactions including refinancing, tender offers, exchanges or otherwise. Debt repurchases, refinancing or exchanges, if any, will depend on prevailing market
conditions, Company liquidity requirements, restrictive financial covenants and other factors applicable at the time. The amounts involved may be material.

We believe that on-hand cash combined with cash generated from operations, including our Mexican operations, will be sufficient to meet
our obligations such as debt service, tax payments, capital expenditures and working capital requirements for at least



31



---

##### Table of Contents

the next twelve months. We expect to fund all these obligations through our existing cash and our future operating cash flows. However, future operating performance for the Company is subject to
prevailing economic and competitive conditions and various other factors that are uncertain. If the cash flows and other capital resources available to the Company are insufficient to fund our debt and other liquidity needs, the Company may have to
take alternative actions that differ from the Companys current operating plan.

Were subject to Rhodias
ability to perform its obligations under our 2004 acquisition agreements, primarily to indemnify us (or provide security) against potential liabilities such as the CNA Fresh Water Claims currently estimated at $24 million for the periods through
2002. Even though our indemnification rights have been confirmed by court judgments, ultimately we are also dependent on Rhodia having sufficient financial capacity to meet its obligations should they arise. Rhodias financial position has
improved significantly in recent quarters and we currently see no reason to suspect they would be unable to meet their obligations.

If the CNA Fresh Water Claims were sustained for the periods through 2002, it is possible that the CNA would seek to claim similar higher
duties, fees and other charges for fresh water extraction and usage from 2005 on into the future (2003 and 2004 are believed to be beyond the statute of limitations). Management estimates that amounts involved would be approximately $13 million of
additional basic charges, interest, inflation, and penalties, and, under current operating conditions, approximately $1.6 million of additional basic charges per year. Although not included in our court judgments in the New York Litigation against
Rhodia, we believe Rhodia is required to indemnify us fully for post-closing losses caused by breaches of covenants set forth in the agreement. Rhodia has contested indemnification responsibility for those breaches, but its motion for
partial summary judgment to dismiss our claims was denied by the New York trial court in January 2009. It is possible that the New York Litigation will proceed to trial or involve further motions to resolve remaining issues. Please refer to Note 12
of Notes to Consolidated Financial Statements in Item 1. Financial Statements for additional information.



|                                            |  |                           |         |      |   |         |  |      |        |      |   |        |  |            |        |  |   |         |  |   |        
|------------------------------------------- |  | ------------------------- | ------- | ---- | - | ------- |  | ---- | ------ | ---- | - | ------ |  | ---------- | ------ |  | - | ------- |  | - | -------
|                                            |  | Years ending December 31,
|Contractual Obligations                     |  | Total                     |         | 2010 |   | 2011    |  | 2012 |        | 2013 |   | 2014   |  | Thereafter
|2004 Senior Subordinated Notes Due 2014 (1) |  |                           | 265,882 |      |   | 8,431   |  |      | 16,863 |      |   | 16,862 |  |            | 16,863 |  |   | 206,863 |  |   |       
|Future service pension benefits             |  |                           | 9,632   |      |   | 537     |  |      | 642    |      |   | 735    |  |            | 825    |  |   | 902     |  |   | 5,991  
|Other (2)                                   |  |                           | 459,249 |      |   | 89,845  |  |      | 48,764 |      |   | 48,764 |  |            | 48,764 |  |   | 48,764  |  |   | 174,348
|Operating leases                            |  |                           | 18,538  |      |   | 4,111   |  |      | 3,688  |      |   | 2,824  |  |            | 2,690  |  |   | 2,246   |  |   | 2,979  
|                                            |  |                           |         |      |   |         |  |      |        |      |   |        |  |            |        |  |   |         |  |   |        
|Total contractual cash obligations          |  | $                         | 753,301 |      | $ | 102,924 |  | $    | 69,957 |      | $ | 69,185 |  | $          | 69,142 |  | $ | 258,775 |  | $ | 183,318
|                                            |  |                           |         |      |   |         |  |      |        |      |   |        |  |            |        |  |   |         |  |   |        



|(1) | Amounts include fixed rate interest payments at 8.875% for years 2010 and thereafter.
|--- | -------------------------------------------------------------------------------------

|(2) | Represents minimum annual purchase commitments to buy raw materials from suppliers.
|--- | -----------------------------------------------------------------------------------

Critical Accounting Estimates

There have been no material changes from the critical accounting estimates previously disclosed in our 2009 Annual Report on Form 10-K.



|ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|------- | ----------------------------------------------------------

We are exposed to certain market risks as part of our ongoing business operations. Primary exposures include changes in interest rates, as
borrowings under our Loan Agreement will bear interest at floating rates based on LIBOR plus an applicable borrowing margin. We manage our interest rate risk by balancing the amount of fixed-rate and floating-rate debt to the extent practicable
consistent with our credit status. For fixed-rate debt, interest rate changes do not affect earnings or cash flows. Conversely, for floating-rate debt, interest rate changes generally affect our earnings and cash flows, assuming other factors are
held constant.

At June 30, 2010, we had $190.0 million principal amount of fixed-rate debt and a $65.0 million revolving
credit facility, which has not been drawn upon, of which we had $55.6 million available above the minimum excess availability requirements.

Changes in economic conditions could result in higher interest rates, thereby increasing our interest expense should we need to draw on
our revolving line of credit. Changes in economic conditions may also result in higher other operating expenses, reducing our funds available for capital investment, operations or other purposes. In addition, a substantial portion of our cash flow
has been used to service debt and funding working capital needs, which may affect our ability to make future acquisitions or capital expenditures. We may from time to time use interest rate protection agreements to minimize our exposure to interest
rate fluctuation. Regardless of hedges, we may experience economic loss and a negative impact on earnings or net assets as a result of interest rate fluctuations.

We do not currently, but may from time to time, hedge our interest rate or currency rate risks. In the second quarter of 2010 we
purchased forward natural gas price cap contracts which allow us to purchase a portion of our monthly natural gas usage requirements at a fixed price if prevailing market prices are greater than this contractual fixed price amount. These contracts
are for periods expiring through April 2011, and apply to our U.S., Canadian and Mexican facilities.



32



---

##### Table of Contents

We believe that our concentration of credit risk related to trade accounts receivable is
limited since these receivables are spread among a number of customers and are geographically dispersed. Our largest customer in 2008 represented 11% of that years sales, otherwise, no other customer accounted for more than 10% of our sales in
the last 3 years.

Foreign Currency Exchange Rates

The U.S. dollar is the functional currency of the Canadian and Mexican operations. Accordingly, these operations monetary assets and
liabilities are translated at current exchange rates, non-monetary assets and liabilities are translated at historical exchange rates, and revenue and expenses are translated at average exchange rates and at historical exchange rates for the related
revenue and expenses of non-monetary assets and liabilities. All translation gains and losses are included in net income.

Our
principal source of exchange rate exposure in our foreign operations consists of expenses, such as labor expenses and utilities, which are denominated in the foreign currency of the country in which we operate. A decline in the value of the U.S.
dollar relative to the local currency would generally cause our operational expenses (particularly labor costs) to increase (conversely, a decline in the value of the foreign currency relative to the U.S. dollar would cause these expenses to
decrease). We believe that normal exchange rate fluctuations consistent with recent historical trends would have a modest impact on our expenses, and would not materially affect our financial condition or results of operations. Nearly all of our
sales and raw material purchases are denominated in U.S. dollars and our exchange rate exposure in terms of sales revenues and raw material costs is minimal.

Inflation and changing prices

Our costs and expenses will be subject to inflation and price fluctuations. Significant price fluctuations in raw materials, freight, and
energy costs, if not compensated for by cost savings from production efficiencies or price increases passed on to customers, could have a material effect on our financial condition and results of operations.

Off-Balance Sheet Arrangements

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as
structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.



|ITEM 4T. | CONTROLS AND PROCEDURES
|-------- | -----------------------

Disclosure Control and Procedures

The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of
1934) that are designed to provide reasonable assurance that information required to be reported in the Companys consolidated financial statements and filings is recorded, processed, summarized and reported within the periods specified in the
rules and forms of the Securities and Exchange Commission, or SEC, and that such information is accumulated and communicated to the Companys management, including its principal executive officer and principal financial officer, as appropriate,
to allow timely decisions regarding required disclosure. Any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives.

As of June 30, 2010, the Company completed an evaluation under the supervision and with the participation of the Companys
management, including the Companys principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Companys disclosure controls and procedures. Based upon that evaluation, the
Principal Executive Officer and Principal Financial Officer concluded that the Companys disclosure controls and procedures are effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting during or with respect to the second quarter of 2010 that have
materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting.



33



---

##### Table of Contents

PART II



|ITEM 1. | LEGAL PROCEEDINGS
|------- | -----------------

The
information set forth in Note 11 to our consolidated condensed financial statements, Commitments and Contingencies, contained in this Quarterly Report on Form 10-Q is incorporated herein by reference.



|ITEM 1A. | RISK FACTORS
|-------- | ------------

There have
been no material changes from the risk factors previously disclosed in our 2009 Annual Report on Form 10-K.



|ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|------- | -----------------------------------------------------------

None.



|ITEM 3. | DEFAULTS UPON SENIOR SECURITIES
|------- | -------------------------------

None.



|ITEM 4. | (REMOVED AND RESERVED)
|------- | ----------------------



|ITEM 5. | OTHER INFORMATION
|------- | -----------------

None.



|ITEM 6. | EXHIBITS
|------- | --------

a) Exhibits.
The following exhibits are filed or furnished as part of this report:



|            |  |                                                                                                                            
|----------- |  | ---------------------------------------------------------------------------------------------------------------------------
|Exhibit No. |  | Description                                                                                                                
|31.1        |  | Certification of Principal Executive Officer dated August 3, 2010 pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|            | 
|31.2        |  | Certification of Principal Financial Officer dated August 3, 2010 pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|            | 
|32.1*       |  | Certification of Principal Executive Officer dated August 3, 2010 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|            | 
|32.2*       |  | Certification of Principal Financial Officer dated August 3, 2010 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



|* | Not to be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, nor deemed to be
incorporated by reference into any filing under that Act or the Securities Act of 1933.
|- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



34



---

##### Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.



INNOPHOS, INC./s/ Randolph GressBy:

Randolph GressIts:

Chief Executive Officer and Director(Principal Executive Officer)Dated: August 3, 2010INNOPHOS, INC./s/ Neil I. SalmonBy:

Neil I. SalmonIts:

Vice President and Chief Financial Officer(Principal Financial Officer)Dated: August 3, 2010




35



---

##### Table of Contents

EXHIBIT INDEX



|            |  |                                                                                                                            
|----------- |  | ---------------------------------------------------------------------------------------------------------------------------
|Exhibit No. |  | Description                                                                                                                
|31.1        |  | Certification of Principal Executive Officer dated August 3, 2010 pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|            | 
|31.2        |  | Certification of Principal Financial Officer dated August 3, 2010 pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|            | 
|32.1        |  | Certification of Principal Executive Officer dated August 3, 2010 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|            | 
|32.2        |  | Certification of Principal Financial Officer dated August 3, 2010 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



36